ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
GO:0051457	maintenance of protein location in nucleus	2/30	23/18866	0.000605733380655422	0.223183822613853	0.184821939187193	BBS4/PML	2
GO:0032094	response to food	2/30	38/18866	0.00165837274149169	0.223183822613853	0.184821939187193	BBS4/CYP1A1	2
GO:0072595	maintenance of protein localization in organelle	2/30	42/18866	0.00202309183939175	0.223183822613853	0.184821939187193	BBS4/PML	2
GO:0060324	face development	2/30	48/18866	0.00263482081737731	0.223183822613853	0.184821939187193	BBS4/STRA6	2
GO:0032507	maintenance of protein location in cell	2/30	64/18866	0.00463537081937024	0.223183822613853	0.184821939187193	BBS4/PML	2
GO:0090398	cellular senescence	2/30	79/18866	0.00698030346503608	0.223183822613853	0.184821939187193	PML/ULK3	2
GO:0019318	hexose metabolic process	3/30	254/18866	0.00748665641227431	0.223183822613853	0.184821939187193	ADPGK/MPI/MAN2C1	3
GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic	2/30	87/18866	0.00840919426192882	0.223183822613853	0.184821939187193	EDC3/RPP25	2
GO:0045185	maintenance of protein location	2/30	93/18866	0.00955976238073485	0.223183822613853	0.184821939187193	BBS4/PML	2
GO:0005996	monosaccharide metabolic process	3/30	296/18866	0.01134955683837	0.223183822613853	0.184821939187193	ADPGK/MPI/MAN2C1	3
GO:0060840	artery development	2/30	102/18866	0.0114093233088075	0.223183822613853	0.184821939187193	LOXL1/STRA6	2
GO:1903076	regulation of protein localization to plasma membrane	2/30	102/18866	0.0114093233088075	0.223183822613853	0.184821939187193	CSK/PTPN9	2
GO:0006892	post-Golgi vesicle-mediated transport	2/30	104/18866	0.0118401291419017	0.223183822613853	0.184821939187193	CSK/SCAMP2	2
GO:0050890	cognition	3/30	302/18866	0.0119795762163081	0.223183822613853	0.184821939187193	BBS4/NPTN/STRA6	3
GO:0070372	regulation of ERK1 and ERK2 cascade	3/30	306/18866	0.0124106513983809	0.223183822613853	0.184821939187193	NPTN/SEMA7A/CSK	3
GO:0001523	retinoid metabolic process	2/30	108/18866	0.0127229826132791	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0007568	aging	3/30	319/18866	0.0138731764512399	0.223183822613853	0.184821939187193	PML/CYP1A1/ULK3	3
GO:0016101	diterpenoid metabolic process	2/30	114/18866	0.014099675876868	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0070371	ERK1 and ERK2 cascade	3/30	325/18866	0.0145801209599859	0.223183822613853	0.184821939187193	NPTN/SEMA7A/CSK	3
GO:0007569	cell aging	2/30	118/18866	0.015051880390497	0.223183822613853	0.184821939187193	PML/ULK3	2
GO:0043010	camera-type eye development	3/30	332/18866	0.0154305366268985	0.223183822613853	0.184821939187193	BBS4/STRA6/CYP1A1	3
GO:0006285	base-excision repair, AP site formation	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	NEIL1	1
GO:0015937	coenzyme A biosynthetic process	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	PPCDC	1
GO:0034454	microtubule anchoring at centrosome	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	BBS4	1
GO:0046548	retinal rod cell development	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	BBS4	1
GO:0097250	mitochondrial respirasome assembly	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	HIGD2B	1
GO:0098598	learned vocalization behavior or vocal learning	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	STRA6	1
GO:0120252	hydrocarbon metabolic process	1/30	10/18866	0.0157920556578653	0.223183822613853	0.184821939187193	CYP1A1	1
GO:1904375	regulation of protein localization to cell periphery	2/30	123/18866	0.0162802104362014	0.223183822613853	0.184821939187193	CSK/PTPN9	2
GO:0006721	terpenoid metabolic process	2/30	124/18866	0.0165308970263526	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0048593	camera-type eye morphogenesis	2/30	125/18866	0.0167832441555617	0.223183822613853	0.184821939187193	BBS4/STRA6	2
GO:0017085	response to insecticide	1/30	11/18866	0.0173579359256983	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0033210	leptin-mediated signaling pathway	1/30	11/18866	0.0173579359256983	0.223183822613853	0.184821939187193	BBS4	1
GO:0048742	regulation of skeletal muscle fiber development	1/30	11/18866	0.0173579359256983	0.223183822613853	0.184821939187193	FBXO22	1
GO:0060368	regulation of Fc receptor mediated stimulatory signaling pathway	1/30	11/18866	0.0173579359256983	0.223183822613853	0.184821939187193	CSK	1
GO:0003356	regulation of cilium beat frequency	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	BBS4	1
GO:0030208	dermatan sulfate biosynthetic process	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	CSPG4	1
GO:0035845	photoreceptor cell outer segment organization	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	BBS4	1
GO:0042178	xenobiotic catabolic process	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0060900	embryonic camera-type eye formation	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	STRA6	1
GO:0072393	microtubule anchoring at microtubule organizing center	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	BBS4	1
GO:0072537	fibroblast activation	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	ULK3	1
GO:1902855	regulation of non-motile cilium assembly	1/30	12/18866	0.0189214077858009	0.223183822613853	0.184821939187193	BBS4	1
GO:0048565	digestive tract development	2/30	135/18866	0.019396832105902	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0001682	tRNA 5'-leader removal	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	RPP25	1
GO:0009223	pyrimidine deoxyribonucleotide catabolic process	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	NEIL1	1
GO:0009313	oligosaccharide catabolic process	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	MAN2C1	1
GO:0030205	dermatan sulfate metabolic process	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	CSPG4	1
GO:0031223	auditory behavior	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	STRA6	1
GO:0032096	negative regulation of response to food	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	BBS4	1
GO:0032099	negative regulation of appetite	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	BBS4	1
GO:0060221	retinal rod cell differentiation	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	BBS4	1
GO:0061029	eyelid development in camera-type eye	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	STRA6	1
GO:0097499	protein localization to non-motile cilium	1/30	13/18866	0.0204824748148893	0.223183822613853	0.184821939187193	BBS4	1
GO:0006720	isoprenoid metabolic process	2/30	144/18866	0.0218860456820506	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0006244	pyrimidine nucleotide catabolic process	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	NEIL1	1
GO:0010935	regulation of macrophage cytokine production	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0010989	negative regulation of low-density lipoprotein particle clearance	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	CSK	1
GO:0030207	chondroitin sulfate catabolic process	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	CSPG4	1
GO:0099550	trans-synaptic signaling, modulating synaptic transmission	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	NPTN	1
GO:0110154	RNA decapping	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	EDC3	1
GO:0110156	methylguanosine-cap decapping	1/30	14/18866	0.0220411405845573	0.223183822613853	0.184821939187193	EDC3	1
GO:0007612	learning	2/30	145/18866	0.0221704562444854	0.223183822613853	0.184821939187193	NPTN/STRA6	2
GO:0001654	eye development	3/30	384/18866	0.0226221662721963	0.223183822613853	0.184821939187193	BBS4/STRA6/CYP1A1	3
GO:0055123	digestive system development	2/30	147/18866	0.0227439123083216	0.223183822613853	0.184821939187193	STRA6/CYP1A1	2
GO:0150063	visual system development	3/30	388/18866	0.0232396634854101	0.223183822613853	0.184821939187193	BBS4/STRA6/CYP1A1	3
GO:0007638	mechanosensory behavior	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	STRA6	1
GO:0009404	toxin metabolic process	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0015936	coenzyme A metabolic process	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	PPCDC	1
GO:0016114	terpenoid biosynthetic process	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0018158	protein oxidation	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	LOXL1	1
GO:0032105	negative regulation of response to extracellular stimulus	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	BBS4	1
GO:0032108	negative regulation of response to nutrient levels	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	BBS4	1
GO:0043584	nose development	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	STRA6	1
GO:0045779	negative regulation of bone resorption	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	CSK	1
GO:0050651	dermatan sulfate proteoglycan biosynthetic process	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	CSPG4	1
GO:0070365	hepatocyte differentiation	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	CYP1A1	1
GO:1902187	negative regulation of viral release from host cell	1/30	15/18866	0.0235974086612845	0.223183822613853	0.184821939187193	PML	1
GO:0031346	positive regulation of cell projection organization	3/30	394/18866	0.0241832000034499	0.223183822613853	0.184821939187193	BBS4/NPTN/SEMA7A	3
GO:0048880	sensory system development	3/30	394/18866	0.0241832000034499	0.223183822613853	0.184821939187193	BBS4/STRA6/CYP1A1	3
GO:0010977	negative regulation of neuron projection development	2/30	154/18866	0.0247991228591639	0.223183822613853	0.184821939187193	SEMA7A/PTPN9	2
GO:0007567	parturition	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0009812	flavonoid metabolic process	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0010934	macrophage cytokine production	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0050655	dermatan sulfate proteoglycan metabolic process	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	CSPG4	1
GO:0070593	dendrite self-avoidance	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	NPTN	1
GO:0099116	tRNA 5'-end processing	1/30	16/18866	0.0251512826064421	0.223183822613853	0.184821939187193	RPP25	1
GO:0048592	eye morphogenesis	2/30	156/18866	0.0253999003437163	0.223183822613853	0.184821939187193	BBS4/STRA6	2
GO:2000058	regulation of ubiquitin-dependent protein catabolic process	2/30	159/18866	0.0263122230644662	0.223183822613853	0.184821939187193	PML/FBXO22	2
GO:0003184	pulmonary valve morphogenesis	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	STRA6	1
GO:0030540	female genitalia development	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	STRA6	1
GO:0030575	nuclear body organization	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	PML	1
GO:0035461	vitamin transmembrane transport	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	STRA6	1
GO:0046851	negative regulation of bone remodeling	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	CSK	1
GO:0050665	hydrogen peroxide biosynthetic process	1/30	17/18866	0.0267027659762988	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0090501	RNA phosphodiester bond hydrolysis	2/30	165/18866	0.0281765237267758	0.223183822613853	0.184821939187193	EDC3/RPP25	2
GO:0021756	striatum development	1/30	18/18866	0.0282518623220315	0.223183822613853	0.184821939187193	BBS4	1
GO:1902683	regulation of receptor localization to synapse	1/30	18/18866	0.0282518623220315	0.223183822613853	0.184821939187193	NPTN	1
GO:0060538	skeletal muscle organ development	2/30	168/18866	0.0291282266824286	0.223183822613853	0.184821939187193	STRA6/FBXO22	2
GO:0009219	pyrimidine deoxyribonucleotide metabolic process	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	NEIL1	1
GO:0010985	negative regulation of lipoprotein particle clearance	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	CSK	1
GO:0032095	regulation of response to food	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	BBS4	1
GO:0033189	response to vitamin A	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0044320	cellular response to leptin stimulus	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	BBS4	1
GO:0045956	positive regulation of calcium ion-dependent exocytosis	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	SCAMP5	1
GO:0061081	positive regulation of myeloid leukocyte cytokine production involved in immune response	1/30	19/18866	0.0297985751897279	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0003085	negative regulation of systemic arterial blood pressure	1/30	20/18866	0.0313429081203962	0.223183822613853	0.184821939187193	BBS4	1
GO:0009264	deoxyribonucleotide catabolic process	1/30	20/18866	0.0313429081203962	0.223183822613853	0.184821939187193	NEIL1	1
GO:0010988	regulation of low-density lipoprotein particle clearance	1/30	20/18866	0.0313429081203962	0.223183822613853	0.184821939187193	CSK	1
GO:0019373	epoxygenase P450 pathway	1/30	20/18866	0.0313429081203962	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0048771	tissue remodeling	2/30	178/18866	0.0323926417984236	0.223183822613853	0.184821939187193	CSK/CSPG4	2
GO:0048732	gland development	3/30	443/18866	0.0326649626086943	0.223183822613853	0.184821939187193	PML/STRA6/CYP1A1	3
GO:0003177	pulmonary valve development	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	STRA6	1
GO:0006123	mitochondrial electron transport, cytochrome c to oxygen	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	COX5A	1
GO:0019646	aerobic electron transport chain	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	COX5A	1
GO:0033962	P-body assembly	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	EDC3	1
GO:0034471	ncRNA 5'-end processing	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	RPP25	1
GO:0046386	deoxyribose phosphate catabolic process	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	NEIL1	1
GO:0060065	uterus development	1/30	21/18866	0.0328848646499721	0.223183822613853	0.184821939187193	STRA6	1
GO:0001819	positive regulation of cytokine production	3/30	447/18866	0.0334182404577009	0.223183822613853	0.184821939187193	CD276/SEMA7A/SCAMP5	3
GO:0032069	regulation of nuclease activity	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	NEIL1	1
GO:0032402	melanosome transport	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	BBS4	1
GO:0034104	negative regulation of tissue remodeling	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	CSK	1
GO:0042359	vitamin D metabolic process	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0050765	negative regulation of phagocytosis	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	CSK	1
GO:0055093	response to hyperoxia	1/30	22/18866	0.0344244483093246	0.223183822613853	0.184821939187193	CYP1A1	1
GO:2000045	regulation of G1/S transition of mitotic cell cycle	2/30	185/18866	0.0347600480020796	0.223183822613853	0.184821939187193	PML/CYP1A1	2
GO:0048639	positive regulation of developmental growth	2/30	187/18866	0.0354486219483517	0.223183822613853	0.184821939187193	BBS4/SEMA7A	2
GO:0031345	negative regulation of cell projection organization	2/30	188/18866	0.0357949134282477	0.223183822613853	0.184821939187193	SEMA7A/PTPN9	2
GO:0000966	RNA 5'-end processing	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	RPP25	1
GO:0009226	nucleotide-sugar biosynthetic process	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	MPI	1
GO:0032098	regulation of appetite	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	BBS4	1
GO:0032401	establishment of melanosome localization	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	BBS4	1
GO:0051904	pigment granule transport	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	BBS4	1
GO:1900273	positive regulation of long-term synaptic potentiation	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	NPTN	1
GO:1903077	negative regulation of protein localization to plasma membrane	1/30	23/18866	0.0359616626242643	0.223183822613853	0.184821939187193	CSK	1
GO:0030308	negative regulation of cell growth	2/30	190/18866	0.0364914813784264	0.223183822613853	0.184821939187193	PML/SEMA7A	2
GO:0021544	subpallium development	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0030325	adrenal gland development	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	STRA6	1
GO:0032469	endoplasmic reticulum calcium ion homeostasis	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	PML	1
GO:0044321	response to leptin	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0045724	positive regulation of cilium assembly	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0048745	smooth muscle tissue development	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	STRA6	1
GO:0051905	establishment of pigment granule localization	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0060295	regulation of cilium movement involved in cell motility	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0060444	branching involved in mammary gland duct morphogenesis	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	PML	1
GO:1902019	regulation of cilium-dependent cell motility	1/30	24/18866	0.0374965111155484	0.223183822613853	0.184821939187193	BBS4	1
GO:0060249	anatomical structure homeostasis	3/30	469/18866	0.0377243988748238	0.223183822613853	0.184821939187193	BBS4/PML/CSK	3
GO:1901136	carbohydrate derivative catabolic process	2/30	195/18866	0.0382559240959785	0.223183822613853	0.184821939187193	NEIL1/CSPG4	2
GO:1905475	regulation of protein localization to membrane	2/30	195/18866	0.0382559240959785	0.223183822613853	0.184821939187193	CSK/PTPN9	2
GO:0031667	response to nutrient levels	3/30	473/18866	0.0385368751571298	0.223183822613853	0.184821939187193	BBS4/CYP1A1/FBXO22	3
GO:0032104	regulation of response to extracellular stimulus	1/30	25/18866	0.0390289972988908	0.223183822613853	0.184821939187193	BBS4	1
GO:0032107	regulation of response to nutrient levels	1/30	25/18866	0.0390289972988908	0.223183822613853	0.184821939187193	BBS4	1
GO:0032400	melanosome localization	1/30	25/18866	0.0390289972988908	0.223183822613853	0.184821939187193	BBS4	1
GO:0048169	regulation of long-term neuronal synaptic plasticity	1/30	25/18866	0.0390289972988908	0.223183822613853	0.184821939187193	NPTN	1
GO:1904376	negative regulation of protein localization to cell periphery	1/30	25/18866	0.0390289972988908	0.223183822613853	0.184821939187193	CSK	1
GO:0016052	carbohydrate catabolic process	2/30	200/18866	0.0400527824172675	0.223183822613853	0.184821939187193	ADPGK/MAN2C1	2
GO:0030206	chondroitin sulfate biosynthetic process	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	CSPG4	1
GO:0034453	microtubule anchoring	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	BBS4	1
GO:0035902	response to immobilization stress	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0048843	negative regulation of axon extension involved in axon guidance	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0051875	pigment granule localization	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	BBS4	1
GO:0060219	camera-type eye photoreceptor cell differentiation	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	BBS4	1
GO:1904861	excitatory synapse assembly	1/30	26/18866	0.0405591246849657	0.223183822613853	0.184821939187193	NPTN	1
GO:0006735	NADH regeneration	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	ADPGK	1
GO:0010996	response to auditory stimulus	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	STRA6	1
GO:0048520	positive regulation of behavior	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	STRA6	1
GO:0061621	canonical glycolysis	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	ADPGK	1
GO:0061718	glucose catabolic process to pyruvate	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	ADPGK	1
GO:1902473	regulation of protein localization to synapse	1/30	27/18866	0.0420868967794161	0.223183822613853	0.184821939187193	NPTN	1
GO:0050852	T cell receptor signaling pathway	2/30	206/18866	0.0422509750418048	0.223183822613853	0.184821939187193	CD276/CSK	2
GO:1902806	regulation of cell cycle G1/S phase transition	2/30	206/18866	0.0422509750418048	0.223183822613853	0.184821939187193	PML/CYP1A1	2
GO:0006929	substrate-dependent cell migration	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	CSPG4	1
GO:0008299	isoprenoid biosynthetic process	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0048596	embryonic camera-type eye morphogenesis	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	STRA6	1
GO:0061620	glycolytic process through glucose-6-phosphate	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	ADPGK	1
GO:0071280	cellular response to copper ion	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	CYP1A1	1
GO:1902668	negative regulation of axon guidance	1/30	28/18866	0.0436123170828622	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0036296	response to increased oxygen levels	1/30	29/18866	0.0451353890909052	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0043153	entrainment of circadian clock by photoperiod	1/30	29/18866	0.0451353890909052	0.223183822613853	0.184821939187193	PML	1
GO:0061615	glycolytic process through fructose-6-phosphate	1/30	29/18866	0.0451353890909052	0.223183822613853	0.184821939187193	ADPGK	1
GO:0050870	positive regulation of T cell activation	2/30	214/18866	0.0452514662697446	0.223183822613853	0.184821939187193	CD276/CSK	2
GO:0070374	positive regulation of ERK1 and ERK2 cascade	2/30	215/18866	0.0456320149899602	0.223183822613853	0.184821939187193	NPTN/SEMA7A	2
GO:0051651	maintenance of location in cell	2/30	216/18866	0.0460137680030189	0.223183822613853	0.184821939187193	BBS4/PML	2
GO:0061082	myeloid leukocyte cytokine production	1/30	30/18866	0.0466561162941367	0.223183822613853	0.184821939187193	SEMA7A	1
GO:1902186	regulation of viral release from host cell	1/30	30/18866	0.0466561162941367	0.223183822613853	0.184821939187193	PML	1
GO:0009394	2'-deoxyribonucleotide metabolic process	1/30	31/18866	0.0481745021781446	0.223183822613853	0.184821939187193	NEIL1	1
GO:0050650	chondroitin sulfate proteoglycan biosynthetic process	1/30	31/18866	0.0481745021781446	0.223183822613853	0.184821939187193	CSPG4	1
GO:0060325	face morphogenesis	1/30	31/18866	0.0481745021781446	0.223183822613853	0.184821939187193	STRA6	1
GO:0071539	protein localization to centrosome	1/30	31/18866	0.0481745021781446	0.223183822613853	0.184821939187193	BBS4	1
GO:1905476	negative regulation of protein localization to membrane	1/30	31/18866	0.0481745021781446	0.223183822613853	0.184821939187193	CSK	1
GO:0045665	negative regulation of neuron differentiation	2/30	225/18866	0.0495029984938071	0.223183822613853	0.184821939187193	SEMA7A/PTPN9	2
GO:1903050	regulation of proteolysis involved in cellular protein catabolic process	2/30	225/18866	0.0495029984938071	0.223183822613853	0.184821939187193	PML/FBXO22	2
GO:0008210	estrogen metabolic process	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0021591	ventricular system development	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	BBS4	1
GO:0048741	skeletal muscle fiber development	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	FBXO22	1
GO:0048841	regulation of axon extension involved in axon guidance	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0060603	mammary gland duct morphogenesis	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	PML	1
GO:0071353	cellular response to interleukin-4	1/30	32/18866	0.0496905502235208	0.223183822613853	0.184821939187193	PML	1
GO:0003352	regulation of cilium movement	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	BBS4	1
GO:0009648	photoperiodism	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	PML	1
GO:0010039	response to iron ion	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0010984	regulation of lipoprotein particle clearance	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	CSK	1
GO:0019692	deoxyribose phosphate metabolic process	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	NEIL1	1
GO:0021988	olfactory lobe development	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	SEMA7A	1
GO:0040018	positive regulation of multicellular organism growth	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	BBS4	1
GO:0042573	retinoic acid metabolic process	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0043928	exonucleolytic catabolism of deadenylated mRNA	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	EDC3	1
GO:0045879	negative regulation of smoothened signaling pathway	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	ULK3	1
GO:0048384	retinoic acid receptor signaling pathway	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	PML	1
GO:1905508	protein localization to microtubule organizing center	1/30	33/18866	0.0512042639058662	0.223183822613853	0.184821939187193	BBS4	1
GO:0009649	entrainment of circadian clock	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	PML	1
GO:0019076	viral release from host cell	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	PML	1
GO:0035890	exit from host	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	PML	1
GO:0035891	exit from host cell	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	PML	1
GO:0042759	long-chain fatty acid biosynthetic process	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0046685	response to arsenic-containing substance	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	CYP1A1	1
GO:0048566	embryonic digestive tract development	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	STRA6	1
GO:0048854	brain morphogenesis	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	BBS4	1
GO:0050715	positive regulation of cytokine secretion	1/30	34/18866	0.0527156466958001	0.223183822613853	0.184821939187193	SCAMP5	1
GO:1903039	positive regulation of leukocyte cell-cell adhesion	2/30	235/18866	0.0534899619512674	0.223183822613853	0.184821939187193	CD276/CSK	2
GO:0000291	nuclear-transcribed mRNA catabolic process, exonucleolytic	1/30	35/18866	0.054224702058965	0.223183822613853	0.184821939187193	EDC3	1
GO:0009262	deoxyribonucleotide metabolic process	1/30	35/18866	0.054224702058965	0.223183822613853	0.184821939187193	NEIL1	1
GO:0014904	myotube cell development	1/30	35/18866	0.054224702058965	0.223183822613853	0.184821939187193	FBXO22	1
GO:0042462	eye photoreceptor cell development	1/30	35/18866	0.054224702058965	0.223183822613853	0.184821939187193	BBS4	1
GO:0070670	response to interleukin-4	1/30	35/18866	0.054224702058965	0.223183822613853	0.184821939187193	PML	1
GO:0046777	protein autophosphorylation	2/30	237/18866	0.0543008871740029	0.223183822613853	0.184821939187193	CSK/ULK3	2
GO:0006007	glucose catabolic process	1/30	36/18866	0.0557314334560353	0.22706300180996	0.188034346847759	ADPGK	1
GO:0060323	head morphogenesis	1/30	36/18866	0.0557314334560353	0.22706300180996	0.188034346847759	STRA6	1
GO:0048048	embryonic eye morphogenesis	1/30	37/18866	0.0572358443427224	0.228209584494701	0.188983849516681	STRA6	1
GO:0048846	axon extension involved in axon guidance	1/30	37/18866	0.0572358443427224	0.228209584494701	0.188983849516681	SEMA7A	1
GO:0060428	lung epithelium development	1/30	37/18866	0.0572358443427224	0.228209584494701	0.188983849516681	STRA6	1
GO:1902284	neuron projection extension involved in neuron projection guidance	1/30	37/18866	0.0572358443427224	0.228209584494701	0.188983849516681	SEMA7A	1
GO:1905314	semi-lunar valve development	1/30	37/18866	0.0572358443427224	0.228209584494701	0.188983849516681	STRA6	1
GO:0072330	monocarboxylic acid biosynthetic process	2/30	246/18866	0.0580043833517419	0.230289743264575	0.190706460829467	CYP1A1/CSPG4	2
GO:0009225	nucleotide-sugar metabolic process	1/30	38/18866	0.0587379381697831	0.231234161655728	0.191488548152879	MPI	1
GO:0045880	positive regulation of smoothened signaling pathway	1/30	38/18866	0.0587379381697831	0.231234161655728	0.191488548152879	ULK3	1
GO:0006778	porphyrin-containing compound metabolic process	1/30	39/18866	0.0602377183830239	0.233202453325151	0.193118520607729	CYP1A1	1
GO:0030204	chondroitin sulfate metabolic process	1/30	39/18866	0.0602377183830239	0.233202453325151	0.193118520607729	CSPG4	1
GO:0031076	embryonic camera-type eye development	1/30	39/18866	0.0602377183830239	0.233202453325151	0.193118520607729	STRA6	1
GO:0072529	pyrimidine-containing compound catabolic process	1/30	39/18866	0.0602377183830239	0.233202453325151	0.193118520607729	NEIL1	1
GO:0045926	negative regulation of growth	2/30	254/18866	0.0613691991956028	0.234141995117686	0.193896569545192	PML/SEMA7A	2
GO:0006284	base-excision repair	1/30	40/18866	0.0617351884233126	0.234141995117686	0.193896569545192	NEIL1	1
GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	1/30	40/18866	0.0617351884233126	0.234141995117686	0.193896569545192	NPTN	1
GO:0043001	Golgi to plasma membrane protein transport	1/30	40/18866	0.0617351884233126	0.234141995117686	0.193896569545192	CSK	1
GO:0071526	semaphorin-plexin signaling pathway	1/30	40/18866	0.0617351884233126	0.234141995117686	0.193896569545192	SEMA7A	1
GO:0006734	NADH metabolic process	1/30	41/18866	0.0632303517265792	0.235781442868299	0.195254221318138	ADPGK	1
GO:0045494	photoreceptor cell maintenance	1/30	41/18866	0.0632303517265792	0.235781442868299	0.195254221318138	BBS4	1
GO:0048286	lung alveolus development	1/30	41/18866	0.0632303517265792	0.235781442868299	0.195254221318138	STRA6	1
GO:0051180	vitamin transport	1/30	41/18866	0.0632303517265792	0.235781442868299	0.195254221318138	STRA6	1
GO:0021537	telencephalon development	2/30	259/18866	0.063506019510258	0.235781442868299	0.195254221318138	BBS4/SEMA7A	2
GO:0007611	learning or memory	2/30	260/18866	0.0639364469942977	0.235781442868299	0.195254221318138	NPTN/STRA6	2
GO:1903362	regulation of cellular protein catabolic process	2/30	260/18866	0.0639364469942977	0.235781442868299	0.195254221318138	PML/FBXO22	2
GO:0001894	tissue homeostasis	2/30	261/18866	0.064367886113162	0.235791790564059	0.195262790403361	BBS4/CSK	2
GO:0034383	low-density lipoprotein particle clearance	1/30	42/18866	0.0647232117238278	0.235791790564059	0.195262790403361	CSK	1
GO:0043406	positive regulation of MAP kinase activity	2/30	264/18866	0.0656682327802853	0.235791790564059	0.195262790403361	CSK/CSPG4	2
GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	PML	1
GO:0017158	regulation of calcium ion-dependent exocytosis	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	SCAMP5	1
GO:0030517	negative regulation of axon extension	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	SEMA7A	1
GO:0045124	regulation of bone resorption	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	CSK	1
GO:0045773	positive regulation of axon extension	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	SEMA7A	1
GO:0046688	response to copper ion	1/30	43/18866	0.0662137718411399	0.235791790564059	0.195262790403361	CYP1A1	1
GO:0050654	chondroitin sulfate proteoglycan metabolic process	1/30	44/18866	0.0677020354996839	0.237112457043798	0.196356454527159	CSPG4	1
GO:0060612	adipose tissue development	1/30	44/18866	0.0677020354996839	0.237112457043798	0.196356454527159	BBS4	1
GO:0097178	ruffle assembly	1/30	44/18866	0.0677020354996839	0.237112457043798	0.196356454527159	CSPG4	1
GO:1902667	regulation of axon guidance	1/30	44/18866	0.0677020354996839	0.237112457043798	0.196356454527159	SEMA7A	1
GO:0090596	sensory organ morphogenesis	2/30	269/18866	0.0678553333662316	0.237112457043798	0.196356454527159	BBS4/STRA6	2
GO:0006775	fat-soluble vitamin metabolic process	1/30	45/18866	0.0691880061157184	0.238174942460361	0.197236314961252	CYP1A1	1
GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1/30	45/18866	0.0691880061157184	0.238174942460361	0.197236314961252	PML	1
GO:0060443	mammary gland morphogenesis	1/30	45/18866	0.0691880061157184	0.238174942460361	0.197236314961252	PML	1
GO:0045927	positive regulation of growth	2/30	274/18866	0.0700668215687049	0.238174942460361	0.197236314961252	BBS4/SEMA7A	2
GO:0001754	eye photoreceptor cell differentiation	1/30	46/18866	0.0706716871006036	0.238174942460361	0.197236314961252	BBS4	1
GO:0006220	pyrimidine nucleotide metabolic process	1/30	46/18866	0.0706716871006036	0.238174942460361	0.197236314961252	NEIL1	1
GO:0010761	fibroblast migration	1/30	46/18866	0.0706716871006036	0.238174942460361	0.197236314961252	PML	1
GO:0017144	drug metabolic process	1/30	46/18866	0.0706716871006036	0.238174942460361	0.197236314961252	CYP1A1	1
GO:0034504	protein localization to nucleus	2/30	277/18866	0.0714052148753832	0.238174942460361	0.197236314961252	BBS4/PML	2
GO:0008542	visual learning	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	NPTN	1
GO:0042572	retinol metabolic process	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	CYP1A1	1
GO:0045776	negative regulation of blood pressure	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	BBS4	1
GO:0046677	response to antibiotic	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	CYP1A1	1
GO:0048806	genitalia development	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	STRA6	1
GO:0050919	negative chemotaxis	1/30	47/18866	0.0721530818608047	0.238174942460361	0.197236314961252	SEMA7A	1
GO:0022409	positive regulation of cell-cell adhesion	2/30	279/18866	0.0723022035710673	0.238174942460361	0.197236314961252	CD276/CSK	2
GO:0072659	protein localization to plasma membrane	2/30	281/18866	0.0732029371316026	0.238174942460361	0.197236314961252	CSK/PTPN9	2
GO:0042461	photoreceptor cell development	1/30	48/18866	0.0736321937978988	0.238174942460361	0.197236314961252	BBS4	1
GO:0060632	regulation of microtubule-based movement	1/30	48/18866	0.0736321937978988	0.238174942460361	0.197236314961252	BBS4	1
GO:1900271	regulation of long-term synaptic potentiation	1/30	48/18866	0.0736321937978988	0.238174942460361	0.197236314961252	NPTN	1
GO:0007411	axon guidance	2/30	284/18866	0.0745609913826173	0.238174942460361	0.197236314961252	NPTN/SEMA7A	2
GO:0097485	neuron projection guidance	2/30	285/18866	0.0750155151056592	0.238174942460361	0.197236314961252	NPTN/SEMA7A	2
GO:0010171	body morphogenesis	1/30	49/18866	0.0751090263085837	0.238174942460361	0.197236314961252	STRA6	1
GO:0034260	negative regulation of GTPase activity	1/30	49/18866	0.0751090263085837	0.238174942460361	0.197236314961252	BBS4	1
GO:0048641	regulation of skeletal muscle tissue development	1/30	49/18866	0.0751090263085837	0.238174942460361	0.197236314961252	FBXO22	1
GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	1/30	49/18866	0.0751090263085837	0.238174942460361	0.197236314961252	CYP1A1	1
GO:2000059	negative regulation of ubiquitin-dependent protein catabolic process	1/30	49/18866	0.0751090263085837	0.238174942460361	0.197236314961252	PML	1
GO:0000082	G1/S transition of mitotic cell cycle	2/30	287/18866	0.0759272980156426	0.238174942460361	0.197236314961252	PML/CYP1A1	2
GO:0008038	neuron recognition	1/30	50/18866	0.0765835827846821	0.238174942460361	0.197236314961252	NPTN	1
GO:0019674	NAD metabolic process	1/30	50/18866	0.0765835827846821	0.238174942460361	0.197236314961252	ADPGK	1
GO:0045806	negative regulation of endocytosis	1/30	50/18866	0.0765835827846821	0.238174942460361	0.197236314961252	SCAMP5	1
GO:0046850	regulation of bone remodeling	1/30	50/18866	0.0765835827846821	0.238174942460361	0.197236314961252	CSK	1
GO:0048546	digestive tract morphogenesis	1/30	50/18866	0.0765835827846821	0.238174942460361	0.197236314961252	STRA6	1
GO:0010976	positive regulation of neuron projection development	2/30	290/18866	0.0773017538601783	0.239464273487265	0.198304029716988	NPTN/SEMA7A	2
GO:0032206	positive regulation of telomere maintenance	1/30	51/18866	0.0780558666131502	0.239464273487265	0.198304029716988	PML	1
GO:0035176	social behavior	1/30	51/18866	0.0780558666131502	0.239464273487265	0.198304029716988	BBS4	1
GO:0048146	positive regulation of fibroblast proliferation	1/30	51/18866	0.0780558666131502	0.239464273487265	0.198304029716988	PML	1
GO:0034976	response to endoplasmic reticulum stress	2/30	294/18866	0.0791468612626635	0.239464273487265	0.198304029716988	PML/SCAMP5	2
GO:0003179	heart valve morphogenesis	1/30	52/18866	0.0795258811760847	0.239464273487265	0.198304029716988	STRA6	1
GO:0033059	cellular pigmentation	1/30	52/18866	0.0795258811760847	0.239464273487265	0.198304029716988	BBS4	1
GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	1/30	52/18866	0.0795258811760847	0.239464273487265	0.198304029716988	PML	1
GO:0050768	negative regulation of neurogenesis	2/30	295/18866	0.0796103450747605	0.239464273487265	0.198304029716988	SEMA7A/PTPN9	2
GO:0007632	visual behavior	1/30	53/18866	0.0809936298507264	0.239464273487265	0.198304029716988	NPTN	1
GO:0009311	oligosaccharide metabolic process	1/30	53/18866	0.0809936298507264	0.239464273487265	0.198304029716988	MAN2C1	1
GO:0048168	regulation of neuronal synaptic plasticity	1/30	53/18866	0.0809936298507264	0.239464273487265	0.198304029716988	NPTN	1
GO:0051703	intraspecies interaction between organisms	1/30	53/18866	0.0809936298507264	0.239464273487265	0.198304029716988	BBS4	1
GO:0072698	protein localization to microtubule cytoskeleton	1/30	53/18866	0.0809936298507264	0.239464273487265	0.198304029716988	BBS4	1
GO:0048562	embryonic organ morphogenesis	2/30	302/18866	0.0828790316199146	0.239464273487265	0.198304029716988	BBS4/STRA6	2
GO:0090068	positive regulation of cell cycle process	2/30	302/18866	0.0828790316199146	0.239464273487265	0.198304029716988	PML/CYP1A1	2
GO:0002720	positive regulation of cytokine production involved in immune response	1/30	55/18866	0.0839223430198759	0.239464273487265	0.198304029716988	SEMA7A	1
GO:0008347	glial cell migration	1/30	55/18866	0.0839223430198759	0.239464273487265	0.198304029716988	CSPG4	1
GO:0030199	collagen fibril organization	1/30	55/18866	0.0839223430198759	0.239464273487265	0.198304029716988	LOXL1	1
GO:0042063	gliogenesis	2/30	307/18866	0.0852393629031978	0.239464273487265	0.198304029716988	CSK/CSPG4	2
GO:0001755	neural crest cell migration	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	SEMA7A	1
GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	PML	1
GO:0010332	response to gamma radiation	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	PML	1
GO:0019320	hexose catabolic process	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	ADPGK	1
GO:0031295	T cell costimulation	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	CSK	1
GO:0031529	ruffle organization	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	CSPG4	1
GO:0044273	sulfur compound catabolic process	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	CSPG4	1
GO:1902017	regulation of cilium assembly	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	BBS4	1
GO:1903307	positive regulation of regulated secretory pathway	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	SCAMP5	1
GO:1905515	non-motile cilium assembly	1/30	56/18866	0.0853833142446591	0.239464273487265	0.198304029716988	BBS4	1
GO:0044843	cell cycle G1/S phase transition	2/30	310/18866	0.0866655641488118	0.239464273487265	0.198304029716988	PML/CYP1A1	2
GO:0019748	secondary metabolic process	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	CYP1A1	1
GO:0042743	hydrogen peroxide metabolic process	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	CYP1A1	1
GO:0044380	protein localization to cytoskeleton	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	BBS4	1
GO:0070936	protein K48-linked ubiquitination	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	UBE2Q2	1
GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	PML	1
GO:0097120	receptor localization to synapse	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	NPTN	1
GO:1902400	intracellular signal transduction involved in G1 DNA damage checkpoint	1/30	57/18866	0.0868420330417173	0.239464273487265	0.198304029716988	PML	1
GO:0046034	ATP metabolic process	2/30	311/18866	0.0871426098942707	0.239464273487265	0.198304029716988	ADPGK/COX5A	2
GO:0090305	nucleic acid phosphodiester bond hydrolysis	2/30	313/18866	0.0880991477753205	0.239464273487265	0.198304029716988	EDC3/RPP25	2
GO:0019369	arachidonic acid metabolic process	1/30	58/18866	0.0882985027641241	0.239464273487265	0.198304029716988	CYP1A1	1
GO:0031294	lymphocyte costimulation	1/30	58/18866	0.0882985027641241	0.239464273487265	0.198304029716988	CSK	1
GO:0048008	platelet-derived growth factor receptor signaling pathway	1/30	59/18866	0.0897527267601403	0.239464273487265	0.198304029716988	CSPG4	1
GO:0050707	regulation of cytokine secretion	1/30	59/18866	0.0897527267601403	0.239464273487265	0.198304029716988	SCAMP5	1
GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	1/30	59/18866	0.0897527267601403	0.239464273487265	0.198304029716988	PML	1
GO:1902402	signal transduction involved in mitotic DNA damage checkpoint	1/30	59/18866	0.0897527267601403	0.239464273487265	0.198304029716988	PML	1
GO:1902403	signal transduction involved in mitotic DNA integrity checkpoint	1/30	59/18866	0.0897527267601403	0.239464273487265	0.198304029716988	PML	1
GO:0009416	response to light stimulus	2/30	319/18866	0.0909880751461332	0.239464273487265	0.198304029716988	NPTN/PML	2
GO:0051961	negative regulation of nervous system development	2/30	319/18866	0.0909880751461332	0.239464273487265	0.198304029716988	SEMA7A/PTPN9	2
GO:0006893	Golgi to plasma membrane transport	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	CSK	1
GO:0035904	aorta development	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	LOXL1	1
GO:0048747	muscle fiber development	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	FBXO22	1
GO:0060042	retina morphogenesis in camera-type eye	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	BBS4	1
GO:0061951	establishment of protein localization to plasma membrane	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	CSK	1
GO:1902808	positive regulation of cell cycle G1/S phase transition	1/30	60/18866	0.0912047083732206	0.239464273487265	0.198304029716988	CYP1A1	1
GO:0007204	positive regulation of cytosolic calcium ion concentration	2/30	322/18866	0.0924432271232109	0.239464273487265	0.198304029716988	NPTN/PML	2
GO:0003170	heart valve development	1/30	61/18866	0.0926544509420179	0.239464273487265	0.198304029716988	STRA6	1
GO:0006027	glycosaminoglycan catabolic process	1/30	61/18866	0.0926544509420179	0.239464273487265	0.198304029716988	CSPG4	1
GO:0033013	tetrapyrrole metabolic process	1/30	61/18866	0.0926544509420179	0.239464273487265	0.198304029716988	CYP1A1	1
GO:0061512	protein localization to cilium	1/30	61/18866	0.0926544509420179	0.239464273487265	0.198304029716988	BBS4	1
GO:1903078	positive regulation of protein localization to plasma membrane	1/30	61/18866	0.0926544509420179	0.239464273487265	0.198304029716988	PTPN9	1
GO:0051235	maintenance of location	2/30	324/18866	0.0934172225109879	0.240768697797657	0.199384243451774	BBS4/PML	2
GO:0050851	antigen receptor-mediated signaling pathway	2/30	325/18866	0.0939053779385482	0.241032892067082	0.199603026769603	CD276/CSK	2
GO:0010830	regulation of myotube differentiation	1/30	63/18866	0.0955472322774185	0.241032892067082	0.199603026769603	FBXO22	1
GO:0031571	mitotic G1 DNA damage checkpoint	1/30	63/18866	0.0955472322774185	0.241032892067082	0.199603026769603	PML	1
GO:0046530	photoreceptor cell differentiation	1/30	63/18866	0.0955472322774185	0.241032892067082	0.199603026769603	BBS4	1
GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	1/30	63/18866	0.0955472322774185	0.241032892067082	0.199603026769603	PML	1
GO:1903037	regulation of leukocyte cell-cell adhesion	2/30	329/18866	0.0958656367991577	0.241032892067082	0.199603026769603	CD276/CSK	2
GO:0060562	epithelial tube morphogenesis	2/30	331/18866	0.0968503001403752	0.241032892067082	0.199603026769603	BBS4/PML	2
GO:0001947	heart looping	1/30	64/18866	0.0969902776973873	0.241032892067082	0.199603026769603	BBS4	1
GO:0030166	proteoglycan biosynthetic process	1/30	64/18866	0.0969902776973873	0.241032892067082	0.199603026769603	CSPG4	1
GO:0044783	G1 DNA damage checkpoint	1/30	64/18866	0.0969902776973873	0.241032892067082	0.199603026769603	PML	1
GO:0044819	mitotic G1/S transition checkpoint	1/30	64/18866	0.0969902776973873	0.241032892067082	0.199603026769603	PML	1
GO:0045453	bone resorption	1/30	64/18866	0.0969902776973873	0.241032892067082	0.199603026769603	CSK	1
GO:0050863	regulation of T cell activation	2/30	332/18866	0.0973437532525781	0.241032892067082	0.199603026769603	CD276/CSK	2
GO:0032496	response to lipopolysaccharide	2/30	334/18866	0.0983328852596528	0.241032892067082	0.199603026769603	LOXL1/CYP1A1	2
GO:0017156	calcium-ion regulated exocytosis	1/30	65/18866	0.098431097379819	0.241032892067082	0.199603026769603	SCAMP5	1
GO:0030837	negative regulation of actin filament polymerization	1/30	65/18866	0.098431097379819	0.241032892067082	0.199603026769603	BBS4	1
GO:0032729	positive regulation of interferon-gamma production	1/30	65/18866	0.098431097379819	0.241032892067082	0.199603026769603	CD276	1
GO:0032715	negative regulation of interleukin-6 production	1/30	66/18866	0.099869694639465	0.241032892067082	0.199603026769603	CSK	1
GO:0032922	circadian regulation of gene expression	1/30	66/18866	0.099869694639465	0.241032892067082	0.199603026769603	PML	1
GO:0046365	monosaccharide catabolic process	1/30	66/18866	0.099869694639465	0.241032892067082	0.199603026769603	ADPGK	1
GO:0050922	negative regulation of chemotaxis	1/30	66/18866	0.099869694639465	0.241032892067082	0.199603026769603	SEMA7A	1
GO:1903829	positive regulation of cellular protein localization	2/30	338/18866	0.100319957165047	0.241032892067082	0.199603026769603	NPTN/PTPN9	2
GO:0006026	aminoglycan catabolic process	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	CSPG4	1
GO:0009166	nucleotide catabolic process	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	NEIL1	1
GO:0033866	nucleoside bisphosphate biosynthetic process	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	PPCDC	1
GO:0034030	ribonucleoside bisphosphate biosynthetic process	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	PPCDC	1
GO:0034033	purine nucleoside bisphosphate biosynthetic process	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	PPCDC	1
GO:0034332	adherens junction organization	1/30	67/18866	0.101306072786317	0.241032892067082	0.199603026769603	CSK	1
GO:0000209	protein polyubiquitination	2/30	340/18866	0.101317842938672	0.241032892067082	0.199603026769603	UBE2Q2/FBXO22	2
GO:1990778	protein localization to cell periphery	2/30	340/18866	0.101317842938672	0.241032892067082	0.199603026769603	CSK/PTPN9	2
GO:0009101	glycoprotein biosynthetic process	2/30	342/18866	0.102318592729455	0.241032892067082	0.199603026769603	MPI/CSPG4	2
GO:0043405	regulation of MAP kinase activity	2/30	342/18866	0.102318592729455	0.241032892067082	0.199603026769603	CSK/CSPG4	2
GO:0034381	plasma lipoprotein particle clearance	1/30	68/18866	0.102740235125612	0.241032892067082	0.199603026769603	CSK	1
GO:0040014	regulation of multicellular organism growth	1/30	68/18866	0.102740235125612	0.241032892067082	0.199603026769603	BBS4	1
GO:1904377	positive regulation of protein localization to cell periphery	1/30	68/18866	0.102740235125612	0.241032892067082	0.199603026769603	PTPN9	1
GO:0010721	negative regulation of cell development	2/30	343/18866	0.102820033271917	0.241032892067082	0.199603026769603	SEMA7A/PTPN9	2
GO:0071902	positive regulation of protein serine/threonine kinase activity	2/30	345/18866	0.103825029003711	0.242778827219203	0.201048862389457	CSK/CSPG4	2
GO:0061371	determination of heart left/right asymmetry	1/30	69/18866	0.104172184957841	0.242981621414163	0.201216799365934	BBS4	1
GO:0003143	embryonic heart tube morphogenesis	1/30	70/18866	0.105601925578751	0.244435345191532	0.202420650274254	BBS4	1
GO:0050771	negative regulation of axonogenesis	1/30	70/18866	0.105601925578751	0.244435345191532	0.202420650274254	SEMA7A	1
GO:0050795	regulation of behavior	1/30	70/18866	0.105601925578751	0.244435345191532	0.202420650274254	STRA6	1
GO:0009615	response to virus	2/30	349/18866	0.105843386342314	0.244435345191532	0.202420650274254	PML/CYP1A1	2
GO:0061180	mammary gland epithelium development	1/30	71/18866	0.10702946027936	0.244746229166552	0.202678098051841	PML	1
GO:0048638	regulation of developmental growth	2/30	353/18866	0.107872722772215	0.244746229166552	0.202678098051841	BBS4/SEMA7A	2
GO:0006913	nucleocytoplasmic transport	2/30	354/18866	0.108381747861908	0.244746229166552	0.202678098051841	PML/FBXO22	2
GO:0000281	mitotic cytokinesis	1/30	72/18866	0.108454792345953	0.244746229166552	0.202678098051841	BBS4	1
GO:0003407	neural retina development	1/30	72/18866	0.108454792345953	0.244746229166552	0.202678098051841	BBS4	1
GO:0050663	cytokine secretion	1/30	72/18866	0.108454792345953	0.244746229166552	0.202678098051841	SCAMP5	1
GO:0070988	demethylation	1/30	72/18866	0.108454792345953	0.244746229166552	0.202678098051841	CYP1A1	1
GO:0002237	response to molecule of bacterial origin	2/30	356/18866	0.109401804506738	0.244746229166552	0.202678098051841	LOXL1/CYP1A1	2
GO:0072401	signal transduction involved in DNA integrity checkpoint	1/30	73/18866	0.109877925060097	0.244746229166552	0.202678098051841	PML	1
GO:0072422	signal transduction involved in DNA damage checkpoint	1/30	73/18866	0.109877925060097	0.244746229166552	0.202678098051841	PML	1
GO:1901292	nucleoside phosphate catabolic process	1/30	73/18866	0.109877925060097	0.244746229166552	0.202678098051841	NEIL1	1
GO:1902117	positive regulation of organelle assembly	1/30	73/18866	0.109877925060097	0.244746229166552	0.202678098051841	BBS4	1
GO:0051169	nuclear transport	2/30	357/18866	0.109912829604272	0.244746229166552	0.202678098051841	PML/FBXO22	2
GO:0051251	positive regulation of lymphocyte activation	2/30	357/18866	0.109912829604272	0.244746229166552	0.202678098051841	CD276/CSK	2
GO:0051480	regulation of cytosolic calcium ion concentration	2/30	357/18866	0.109912829604272	0.244746229166552	0.202678098051841	NPTN/PML	2
GO:0001666	response to hypoxia	2/30	359/18866	0.110936857265118	0.245822017114356	0.20356897451564	PML/CYP1A1	2
GO:0072395	signal transduction involved in cell cycle checkpoint	1/30	74/18866	0.111298861698643	0.245822017114356	0.20356897451564	PML	1
GO:1903051	negative regulation of proteolysis involved in cellular protein catabolic process	1/30	74/18866	0.111298861698643	0.245822017114356	0.20356897451564	PML	1
GO:0001818	negative regulation of cytokine production	2/30	360/18866	0.111449853418406	0.245822017114356	0.20356897451564	NPTN/CSK	2
GO:0048844	artery morphogenesis	1/30	75/18866	0.112717605533735	0.248031900856072	0.205399013062963	STRA6	1
GO:0007159	leukocyte cell-cell adhesion	2/30	364/18866	0.113508312435076	0.249184130592766	0.206353192142033	CD276/CSK	2
GO:0003281	ventricular septum development	1/30	76/18866	0.114134159832814	0.24938447570027	0.206519100991705	STRA6	1
GO:0008306	associative learning	1/30	76/18866	0.114134159832814	0.24938447570027	0.206519100991705	NPTN	1
GO:0046394	carboxylic acid biosynthetic process	2/30	367/18866	0.115058866072294	0.250817574872548	0.207705872348903	CYP1A1/CSPG4	2
GO:0016053	organic acid biosynthetic process	2/30	368/18866	0.115576978450095	0.251359722363492	0.208154832983363	CYP1A1/CSPG4	2
GO:0045862	positive regulation of proteolysis	2/30	370/18866	0.116615076158472	0.251813379145739	0.208530513107657	PML/FBXO22	2
GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	1/30	78/18866	0.11696071286923	0.251813379145739	0.208530513107657	EDC3	1
GO:0001895	retina homeostasis	1/30	78/18866	0.11696071286923	0.251813379145739	0.208530513107657	BBS4	1
GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	1/30	78/18866	0.11696071286923	0.251813379145739	0.208530513107657	PML	1
GO:0036293	response to decreased oxygen levels	2/30	371/18866	0.117135055251072	0.251813379145739	0.208530513107657	PML/CYP1A1	2
GO:0032272	negative regulation of protein polymerization	1/30	79/18866	0.118370718118002	0.252844440434378	0.20938435074049	BBS4	1
GO:0070373	negative regulation of ERK1 and ERK2 cascade	1/30	79/18866	0.118370718118002	0.252844440434378	0.20938435074049	CSK	1
GO:0018108	peptidyl-tyrosine phosphorylation	2/30	374/18866	0.118698676216782	0.252844440434378	0.20938435074049	CSK/CSPG4	2
GO:0048193	Golgi vesicle transport	2/30	374/18866	0.118698676216782	0.252844440434378	0.20938435074049	CSK/SCAMP2	2
GO:0014032	neural crest cell development	1/30	80/18866	0.119778546853642	0.253409034499881	0.209851899726872	SEMA7A	1
GO:0032204	regulation of telomere maintenance	1/30	80/18866	0.119778546853642	0.253409034499881	0.209851899726872	PML	1
GO:0035050	embryonic heart tube development	1/30	80/18866	0.119778546853642	0.253409034499881	0.209851899726872	BBS4	1
GO:0018212	peptidyl-tyrosine modification	2/30	377/18866	0.120267757862642	0.253868366710056	0.210232279759893	CSK/CSPG4	2
GO:0021766	hippocampus development	1/30	81/18866	0.12118420232018	0.254650587307945	0.210880048608374	BBS4	1
GO:0071158	positive regulation of cell cycle arrest	1/30	81/18866	0.12118420232018	0.254650587307945	0.210880048608374	PML	1
GO:0045666	positive regulation of neuron differentiation	2/30	380/18866	0.121842217324455	0.255457952278016	0.211548639896275	NPTN/SEMA7A	2
GO:0032535	regulation of cellular component size	2/30	383/18866	0.123421972354719	0.25818991077792	0.213811016540863	BBS4/SEMA7A	2
GO:0002718	regulation of cytokine production involved in immune response	1/30	83/18866	0.12398900639877	0.258218176272439	0.213834423629458	SEMA7A	1
GO:0048145	regulation of fibroblast proliferation	1/30	83/18866	0.12398900639877	0.258218176272439	0.213834423629458	PML	1
GO:0014031	mesenchymal cell development	1/30	84/18866	0.125388161475598	0.259395021411824	0.214808987100219	SEMA7A	1
GO:0048144	fibroblast proliferation	1/30	84/18866	0.125388161475598	0.259395021411824	0.214808987100219	PML	1
GO:0048864	stem cell development	1/30	84/18866	0.125388161475598	0.259395021411824	0.214808987100219	SEMA7A	1
GO:0035418	protein localization to synapse	1/30	85/18866	0.126785156212885	0.260541612395835	0.215758496641894	NPTN	1
GO:0072527	pyrimidine-containing compound metabolic process	1/30	85/18866	0.126785156212885	0.260541612395835	0.215758496641894	NEIL1	1
GO:2000779	regulation of double-strand break repair	1/30	85/18866	0.126785156212885	0.260541612395835	0.215758496641894	PML	1
GO:0030900	forebrain development	2/30	391/18866	0.127659922985412	0.260541612395835	0.215758496641894	BBS4/SEMA7A	2
GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	1/30	86/18866	0.128179993831415	0.260541612395835	0.215758496641894	PML	1
GO:0008589	regulation of smoothened signaling pathway	1/30	86/18866	0.128179993831415	0.260541612395835	0.215758496641894	ULK3	1
GO:0050772	positive regulation of axonogenesis	1/30	86/18866	0.128179993831415	0.260541612395835	0.215758496641894	SEMA7A	1
GO:1903901	negative regulation of viral life cycle	1/30	86/18866	0.128179993831415	0.260541612395835	0.215758496641894	PML	1
GO:0006869	lipid transport	2/30	393/18866	0.128725024638134	0.260541612395835	0.215758496641894	STOML1/STRA6	2
GO:0009060	aerobic respiration	1/30	87/18866	0.129572677547339	0.260541612395835	0.215758496641894	COX5A	1
GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	1/30	87/18866	0.129572677547339	0.260541612395835	0.215758496641894	FBXO22	1
GO:0060291	long-term synaptic potentiation	1/30	87/18866	0.129572677547339	0.260541612395835	0.215758496641894	NPTN	1
GO:1903363	negative regulation of cellular protein catabolic process	1/30	87/18866	0.129572677547339	0.260541612395835	0.215758496641894	PML	1
GO:0045787	positive regulation of cell cycle	2/30	396/18866	0.13032679159684	0.260933254420282	0.216082821396161	PML/CYP1A1	2
GO:0070482	response to oxygen levels	2/30	396/18866	0.13032679159684	0.260933254420282	0.216082821396161	PML/CYP1A1	2
GO:0042176	regulation of protein catabolic process	2/30	397/18866	0.130861799396989	0.261443380808118	0.216505264865074	PML/FBXO22	2
GO:0014033	neural crest cell differentiation	1/30	89/18866	0.132351596112862	0.263742191905223	0.218408945516369	SEMA7A	1
GO:0009150	purine ribonucleotide metabolic process	2/30	401/18866	0.133007180396359	0.263742191905223	0.218408945516369	ADPGK/PPCDC	2
GO:0006029	proteoglycan metabolic process	1/30	90/18866	0.133737837371669	0.263742191905223	0.218408945516369	CSPG4	1
GO:0032465	regulation of cytokinesis	1/30	90/18866	0.133737837371669	0.263742191905223	0.218408945516369	BBS4	1
GO:0001843	neural tube closure	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	BBS4	1
GO:0033273	response to vitamin	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	CYP1A1	1
GO:0034103	regulation of tissue remodeling	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	CSK	1
GO:0045921	positive regulation of exocytosis	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	SCAMP5	1
GO:0046849	bone remodeling	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	CSK	1
GO:0051492	regulation of stress fiber assembly	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	BBS4	1
GO:0060333	interferon-gamma-mediated signaling pathway	1/30	91/18866	0.135121937546299	0.263742191905223	0.218408945516369	PML	1
GO:0002696	positive regulation of leukocyte activation	2/30	406/18866	0.135700727208744	0.264318952997408	0.218886570203754	CD276/CSK	2
GO:0007517	muscle organ development	2/30	407/18866	0.136240983981195	0.264777834805087	0.219266577251575	STRA6/FBXO22	2
GO:0060606	tube closure	1/30	92/18866	0.136503899829846	0.264777834805087	0.219266577251575	BBS4	1
GO:0060537	muscle tissue development	2/30	409/18866	0.137323022177121	0.26581406574949	0.220124695955464	STRA6/FBXO22	2
GO:0034308	primary alcohol metabolic process	1/30	94/18866	0.139261423473121	0.2678987795885	0.221851079390713	CYP1A1	1
GO:0098876	vesicle-mediated transport to the plasma membrane	1/30	94/18866	0.139261423473121	0.2678987795885	0.221851079390713	CSK	1
GO:1901992	positive regulation of mitotic cell cycle phase transition	1/30	94/18866	0.139261423473121	0.2678987795885	0.221851079390713	CYP1A1	1
GO:0009100	glycoprotein metabolic process	2/30	415/18866	0.140581130947458	0.269433907158037	0.223122342025158	MPI/CSPG4	2
GO:0003073	regulation of systemic arterial blood pressure	1/30	95/18866	0.140636991196103	0.269433907158037	0.223122342025158	BBS4	1
GO:0009259	ribonucleotide metabolic process	2/30	416/18866	0.141125868806453	0.269816466386108	0.223439145176739	ADPGK/PPCDC	2
GO:0001558	regulation of cell growth	2/30	420/18866	0.143309631862037	0.270252882382295	0.22380054794224	PML/SEMA7A	2
GO:0030516	regulation of axon extension	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	SEMA7A	1
GO:0036473	cell death in response to oxidative stress	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	PML	1
GO:0042775	mitochondrial ATP synthesis coupled electron transport	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	COX5A	1
GO:0050764	regulation of phagocytosis	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	CSK	1
GO:1990823	response to leukemia inhibitory factor	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	PML	1
GO:1990830	cellular response to leukemia inhibitory factor	1/30	97/18866	0.143381754318581	0.270252882382295	0.22380054794224	PML	1
GO:0050867	positive regulation of cell activation	2/30	421/18866	0.143856761741469	0.270601529646755	0.224089268077755	CD276/CSK	2
GO:0010771	negative regulation of cell morphogenesis involved in differentiation	1/30	98/18866	0.144750956053913	0.270646577150904	0.224126572605363	SEMA7A	1
GO:0014020	primary neural tube formation	1/30	98/18866	0.144750956053913	0.270646577150904	0.224126572605363	BBS4	1
GO:0042773	ATP synthesis coupled electron transport	1/30	98/18866	0.144750956053913	0.270646577150904	0.224126572605363	COX5A	1
GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	2/30	424/18866	0.145500961382991	0.271504793940661	0.224837275063401	PML/FBXO22	2
GO:0043473	pigmentation	1/30	99/18866	0.146118042121602	0.272112042513881	0.225340146900421	BBS4	1
GO:0019693	ribose phosphate metabolic process	2/30	427/18866	0.147149318846824	0.272878819633669	0.225975126768334	ADPGK/PPCDC	2
GO:0002702	positive regulation of production of molecular mediator of immune response	1/30	100/18866	0.147483015678183	0.272878819633669	0.225975126768334	SEMA7A	1
GO:0061640	cytoskeleton-dependent cytokinesis	1/30	100/18866	0.147483015678183	0.272878819633669	0.225975126768334	BBS4	1
GO:0045785	positive regulation of cell adhesion	2/30	428/18866	0.147699682652736	0.272878819633669	0.225975126768334	CD276/CSK	2
GO:0010522	regulation of calcium ion transport into cytosol	1/30	101/18866	0.148845879875649	0.27337245260626	0.226383911787663	PML	1
GO:0042102	positive regulation of T cell proliferation	1/30	101/18866	0.148845879875649	0.27337245260626	0.226383911787663	CD276	1
GO:0044773	mitotic DNA damage checkpoint	1/30	101/18866	0.148845879875649	0.27337245260626	0.226383911787663	PML	1
GO:0019216	regulation of lipid metabolic process	2/30	431/18866	0.149353470338235	0.273765791405842	0.226709641667387	BBS4/CYP1A1	2
GO:0110020	regulation of actomyosin structure organization	1/30	102/18866	0.150206637861459	0.273965187843087	0.2268747649087	BBS4	1
GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process	1/30	102/18866	0.150206637861459	0.273965187843087	0.2268747649087	FBXO22	1
GO:0032102	negative regulation of response to external stimulus	2/30	433/18866	0.150458215587527	0.273965187843087	0.2268747649087	BBS4/SEMA7A	2
GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	1/30	103/18866	0.151565292778543	0.273965187843087	0.2268747649087	PML	1
GO:0035335	peptidyl-tyrosine dephosphorylation	1/30	103/18866	0.151565292778543	0.273965187843087	0.2268747649087	PTPN9	1
GO:0048709	oligodendrocyte differentiation	1/30	103/18866	0.151565292778543	0.273965187843087	0.2268747649087	CSK	1
GO:0002367	cytokine production involved in immune response	1/30	104/18866	0.152921847765307	0.273965187843087	0.2268747649087	SEMA7A	1
GO:0032231	regulation of actin filament bundle assembly	1/30	104/18866	0.152921847765307	0.273965187843087	0.2268747649087	BBS4	1
GO:0032649	regulation of interferon-gamma production	1/30	104/18866	0.152921847765307	0.273965187843087	0.2268747649087	CD276	1
GO:0048525	negative regulation of viral process	1/30	104/18866	0.152921847765307	0.273965187843087	0.2268747649087	PML	1
GO:0120034	positive regulation of plasma membrane bounded cell projection assembly	1/30	104/18866	0.152921847765307	0.273965187843087	0.2268747649087	BBS4	1
GO:0022407	regulation of cell-cell adhesion	2/30	439/18866	0.153782874215502	0.273965187843087	0.2268747649087	CD276/CSK	2
GO:0007631	feeding behavior	1/30	105/18866	0.15427630595564	0.273965187843087	0.2268747649087	STRA6	1
GO:0097006	regulation of plasma lipoprotein particle levels	1/30	105/18866	0.15427630595564	0.273965187843087	0.2268747649087	CSK	1
GO:1902414	protein localization to cell junction	1/30	105/18866	0.15427630595564	0.273965187843087	0.2268747649087	NPTN	1
GO:0010876	lipid localization	2/30	440/18866	0.154338476316657	0.273965187843087	0.2268747649087	STOML1/STRA6	2
GO:0006163	purine nucleotide metabolic process	2/30	442/18866	0.155450936105749	0.273965187843087	0.2268747649087	ADPGK/PPCDC	2
GO:0001841	neural tube formation	1/30	106/18866	0.155628670478924	0.273965187843087	0.2268747649087	BBS4	1
GO:0030038	contractile actin filament bundle assembly	1/30	106/18866	0.155628670478924	0.273965187843087	0.2268747649087	BBS4	1
GO:0043149	stress fiber assembly	1/30	106/18866	0.155628670478924	0.273965187843087	0.2268747649087	BBS4	1
GO:0071156	regulation of cell cycle arrest	1/30	106/18866	0.155628670478924	0.273965187843087	0.2268747649087	PML	1
GO:0030330	DNA damage response, signal transduction by p53 class mediator	1/30	107/18866	0.156978944460035	0.274786782703963	0.227555140186957	PML	1
GO:0034404	nucleobase-containing small molecule biosynthetic process	1/30	107/18866	0.156978944460035	0.274786782703963	0.227555140186957	NEIL1	1
GO:0050905	neuromuscular process	1/30	107/18866	0.156978944460035	0.274786782703963	0.227555140186957	STRA6	1
GO:0009314	response to radiation	2/30	447/18866	0.158239288803291	0.275082333782223	0.227799890558077	NPTN/PML	2
GO:0006024	glycosaminoglycan biosynthetic process	1/30	108/18866	0.15832713101935	0.275082333782223	0.227799890558077	CSPG4	1
GO:0007229	integrin-mediated signaling pathway	1/30	108/18866	0.15832713101935	0.275082333782223	0.227799890558077	SEMA7A	1
GO:0044774	mitotic DNA integrity checkpoint	1/30	108/18866	0.15832713101935	0.275082333782223	0.227799890558077	PML	1
GO:1901990	regulation of mitotic cell cycle phase transition	2/30	448/18866	0.158798173553106	0.275387910641352	0.228052943431774	PML/CYP1A1	2
GO:0021761	limbic system development	1/30	109/18866	0.159673233272758	0.276191452999894	0.228718369156566	BBS4	1
GO:0048568	embryonic organ development	2/30	451/18866	0.160477210138067	0.276191452999894	0.228718369156566	BBS4/STRA6	2
GO:0006289	nucleotide-excision repair	1/30	110/18866	0.161017254331659	0.276191452999894	0.228718369156566	NEIL1	1
GO:1901800	positive regulation of proteasomal protein catabolic process	1/30	110/18866	0.161017254331659	0.276191452999894	0.228718369156566	FBXO22	1
GO:1901989	positive regulation of cell cycle phase transition	1/30	110/18866	0.161017254331659	0.276191452999894	0.228718369156566	CYP1A1	1
GO:0044282	small molecule catabolic process	2/30	452/18866	0.161037674632307	0.276191452999894	0.228718369156566	ADPGK/CYP1A1	2
GO:0060294	cilium movement involved in cell motility	1/30	111/18866	0.162359197302978	0.277437969017726	0.229750628148035	BBS4	1
GO:0061387	regulation of extent of cell growth	1/30	111/18866	0.162359197302978	0.277437969017726	0.229750628148035	SEMA7A	1
GO:0006874	cellular calcium ion homeostasis	2/30	456/18866	0.163283393332099	0.278507140729156	0.230636025605236	NPTN/PML	2
GO:0006979	response to oxidative stress	2/30	458/18866	0.164408533938413	0.279914529497334	0.231801505783318	PML/NEIL1	2
GO:0001676	long-chain fatty acid metabolic process	1/30	113/18866	0.1650368613882	0.279962530318528	0.231841255997968	CYP1A1	1
GO:1903510	mucopolysaccharide metabolic process	1/30	113/18866	0.1650368613882	0.279962530318528	0.231841255997968	CSPG4	1
GO:0003279	cardiac septum development	1/30	114/18866	0.166372588693609	0.281716198277926	0.233293495273874	STRA6	1
GO:0006023	aminoglycan biosynthetic process	1/30	115/18866	0.167706250294462	0.281927804549069	0.233468729665501	CSPG4	1
GO:0006096	glycolytic process	1/30	115/18866	0.167706250294462	0.281927804549069	0.233468729665501	ADPGK	1
GO:0032609	interferon-gamma production	1/30	115/18866	0.167706250294462	0.281927804549069	0.233468729665501	CD276	1
GO:0048640	negative regulation of developmental growth	1/30	115/18866	0.167706250294462	0.281927804549069	0.233468729665501	SEMA7A	1
GO:0006757	ATP generation from ADP	1/30	116/18866	0.169037849275379	0.282638554433564	0.234057312522407	ADPGK	1
GO:0022904	respiratory electron transport chain	1/30	116/18866	0.169037849275379	0.282638554433564	0.234057312522407	COX5A	1
GO:1903828	negative regulation of cellular protein localization	1/30	116/18866	0.169037849275379	0.282638554433564	0.234057312522407	CSK	1
GO:0055074	calcium ion homeostasis	2/30	468/18866	0.170056254299623	0.283832710664666	0.235046211573154	NPTN/PML	2
GO:0014902	myotube differentiation	1/30	117/18866	0.170367388716538	0.283844238700947	0.235055758116427	FBXO22	1
GO:0006805	xenobiotic metabolic process	1/30	118/18866	0.171694871693684	0.284027154769871	0.235207233712512	CYP1A1	1
GO:0008543	fibroblast growth factor receptor signaling pathway	1/30	118/18866	0.171694871693684	0.284027154769871	0.235207233712512	NPTN	1
GO:0021987	cerebral cortex development	1/30	118/18866	0.171694871693684	0.284027154769871	0.235207233712512	BBS4	1
GO:0033559	unsaturated fatty acid metabolic process	1/30	118/18866	0.171694871693684	0.284027154769871	0.235207233712512	CYP1A1	1
GO:0072521	purine-containing compound metabolic process	2/30	472/18866	0.172325250888464	0.284204121641717	0.235353782687449	ADPGK/PPCDC	2
GO:0051346	negative regulation of hydrolase activity	2/30	473/18866	0.172893354394755	0.284204121641717	0.235353782687449	BBS4/NEIL1	2
GO:0046660	female sex differentiation	1/30	119/18866	0.17302030127813	0.284204121641717	0.235353782687449	STRA6	1
GO:0051153	regulation of striated muscle cell differentiation	1/30	119/18866	0.17302030127813	0.284204121641717	0.235353782687449	FBXO22	1
GO:0006304	DNA modification	1/30	120/18866	0.174343680536766	0.285630497011464	0.236534985960868	NEIL1	1
GO:0120254	olefinic compound metabolic process	1/30	121/18866	0.175665012532066	0.285630497011464	0.236534985960868	CYP1A1	1
GO:0001539	cilium or flagellum-dependent cell motility	1/30	122/18866	0.176984300322092	0.285630497011464	0.236534985960868	BBS4	1
GO:0006690	icosanoid metabolic process	1/30	122/18866	0.176984300322092	0.285630497011464	0.236534985960868	CYP1A1	1
GO:0042752	regulation of circadian rhythm	1/30	122/18866	0.176984300322092	0.285630497011464	0.236534985960868	PML	1
GO:0060285	cilium-dependent cell motility	1/30	122/18866	0.176984300322092	0.285630497011464	0.236534985960868	BBS4	1
GO:0001667	ameboidal-type cell migration	2/30	481/18866	0.177450112438686	0.285630497011464	0.236534985960868	PML/SEMA7A	2
GO:0002429	immune response-activating cell surface receptor signaling pathway	2/30	481/18866	0.177450112438686	0.285630497011464	0.236534985960868	CD276/CSK	2
GO:0002757	immune response-activating signal transduction	2/30	481/18866	0.177450112438686	0.285630497011464	0.236534985960868	CD276/CSK	2
GO:0007409	axonogenesis	2/30	482/18866	0.178021162927441	0.285630497011464	0.236534985960868	NPTN/SEMA7A	2
GO:0048675	axon extension	1/30	123/18866	0.178301546960501	0.285630497011464	0.236534985960868	SEMA7A	1
GO:0071466	cellular response to xenobiotic stimulus	1/30	123/18866	0.178301546960501	0.285630497011464	0.236534985960868	CYP1A1	1
GO:0010498	proteasomal protein catabolic process	2/30	483/18866	0.17859252907697	0.285630497011464	0.236534985960868	PML/FBXO22	2
GO:0042110	T cell activation	2/30	483/18866	0.17859252907697	0.285630497011464	0.236534985960868	CD276/CSK	2
GO:0051051	negative regulation of transport	2/30	483/18866	0.17859252907697	0.285630497011464	0.236534985960868	CSK/SCAMP5	2
GO:0022612	gland morphogenesis	1/30	124/18866	0.179616755496551	0.285630497011464	0.236534985960868	PML	1
GO:0046031	ADP metabolic process	1/30	124/18866	0.179616755496551	0.285630497011464	0.236534985960868	ADPGK	1
GO:0050769	positive regulation of neurogenesis	2/30	485/18866	0.179736199029866	0.285630497011464	0.236534985960868	NPTN/SEMA7A	2
GO:1901987	regulation of cell cycle phase transition	2/30	486/18866	0.180308498184352	0.285630497011464	0.236534985960868	PML/CYP1A1	2
GO:0001838	embryonic epithelial tube formation	1/30	125/18866	0.180929928975108	0.285630497011464	0.236534985960868	BBS4	1
GO:0007098	centrosome cycle	1/30	125/18866	0.180929928975108	0.285630497011464	0.236534985960868	BBS4	1
GO:0007368	determination of left/right symmetry	1/30	125/18866	0.180929928975108	0.285630497011464	0.236534985960868	BBS4	1
GO:0035270	endocrine system development	1/30	125/18866	0.180929928975108	0.285630497011464	0.236534985960868	STRA6	1
GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	1/30	126/18866	0.182241070436649	0.287214389725326	0.237846631757646	PML	1
GO:0016049	cell growth	2/30	490/18866	0.182600735371271	0.287295929344681	0.237914155964343	PML/SEMA7A	2
GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	1/30	127/18866	0.183550182917273	0.287646789994742	0.238204709038349	FBXO22	1
GO:1905477	positive regulation of protein localization to membrane	1/30	127/18866	0.183550182917273	0.287646789994742	0.238204709038349	PTPN9	1
GO:0072503	cellular divalent inorganic cation homeostasis	2/30	492/18866	0.183748646127402	0.287646789994742	0.238204709038349	NPTN/PML	2
GO:1903409	reactive oxygen species biosynthetic process	1/30	128/18866	0.184857269448704	0.288897541701242	0.239240475668428	CYP1A1	1
GO:0002576	platelet degranulation	1/30	129/18866	0.186162333058296	0.290450596560853	0.240526584166149	ISLR	1
GO:0008033	tRNA processing	1/30	130/18866	0.187465376769042	0.291508660875861	0.241402783418381	RPP25	1
GO:0009410	response to xenobiotic stimulus	1/30	130/18866	0.187465376769042	0.291508660875861	0.241402783418381	CYP1A1	1
GO:0003231	cardiac ventricle development	1/30	131/18866	0.188766403599579	0.292071400594373	0.24186879679164	STRA6	1
GO:0006766	vitamin metabolic process	1/30	131/18866	0.188766403599579	0.292071400594373	0.24186879679164	CYP1A1	1
GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	1/30	131/18866	0.188766403599579	0.292071400594373	0.24186879679164	FBXO22	1
GO:0006282	regulation of DNA repair	1/30	132/18866	0.190065416564191	0.292690387904495	0.242381389656343	PML	1
GO:1902807	negative regulation of cell cycle G1/S phase transition	1/30	132/18866	0.190065416564191	0.292690387904495	0.242381389656343	PML	1
GO:0006165	nucleoside diphosphate phosphorylation	1/30	133/18866	0.191362418672821	0.292690387904495	0.242381389656343	ADPGK	1
GO:0006997	nucleus organization	1/30	133/18866	0.191362418672821	0.292690387904495	0.242381389656343	PML	1
GO:0042177	negative regulation of protein catabolic process	1/30	133/18866	0.191362418672821	0.292690387904495	0.242381389656343	PML	1
GO:0042770	signal transduction in response to DNA damage	1/30	133/18866	0.191362418672821	0.292690387904495	0.242381389656343	PML	1
GO:0072175	epithelial tube formation	1/30	133/18866	0.191362418672821	0.292690387904495	0.242381389656343	BBS4	1
GO:0009855	determination of bilateral symmetry	1/30	134/18866	0.192657412931072	0.29322898248726	0.242827408073164	BBS4	1
GO:0034754	cellular hormone metabolic process	1/30	134/18866	0.192657412931072	0.29322898248726	0.242827408073164	CYP1A1	1
GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	1/30	134/18866	0.192657412931072	0.29322898248726	0.242827408073164	PML	1
GO:0009799	specification of symmetry	1/30	135/18866	0.193950402340215	0.29423695184296	0.243662122922923	BBS4	1
GO:0046939	nucleotide phosphorylation	1/30	135/18866	0.193950402340215	0.29423695184296	0.243662122922923	ADPGK	1
GO:0009135	purine nucleoside diphosphate metabolic process	1/30	136/18866	0.195241389897195	0.294281448746499	0.243698971489739	ADPGK	1
GO:0009179	purine ribonucleoside diphosphate metabolic process	1/30	136/18866	0.195241389897195	0.294281448746499	0.243698971489739	ADPGK	1
GO:0031023	microtubule organizing center organization	1/30	136/18866	0.195241389897195	0.294281448746499	0.243698971489739	BBS4	1
GO:0050671	positive regulation of lymphocyte proliferation	1/30	136/18866	0.195241389897195	0.294281448746499	0.243698971489739	CD276	1
GO:0030534	adult behavior	1/30	137/18866	0.196530378594637	0.295270278951363	0.244517836915779	BBS4	1
GO:0032946	positive regulation of mononuclear cell proliferation	1/30	137/18866	0.196530378594637	0.295270278951363	0.244517836915779	CD276	1
GO:0033865	nucleoside bisphosphate metabolic process	1/30	138/18866	0.197817371420851	0.295775012076369	0.244935814141203	PPCDC	1
GO:0033875	ribonucleoside bisphosphate metabolic process	1/30	138/18866	0.197817371420851	0.295775012076369	0.244935814141203	PPCDC	1
GO:0034032	purine nucleoside bisphosphate metabolic process	1/30	138/18866	0.197817371420851	0.295775012076369	0.244935814141203	PPCDC	1
GO:0009185	ribonucleoside diphosphate metabolic process	1/30	139/18866	0.199102371359839	0.297220019965968	0.246132447289469	ADPGK	1
GO:0009308	amine metabolic process	1/30	140/18866	0.200385381391302	0.298181117764091	0.24692834708506	CYP1A1	1
GO:0009411	response to UV	1/30	140/18866	0.200385381391302	0.298181117764091	0.24692834708506	PML	1
GO:0001889	liver development	1/30	141/18866	0.201666404490643	0.29960948310473	0.248111198283829	CYP1A1	1
GO:0007224	smoothened signaling pathway	1/30	142/18866	0.202945443628976	0.300076226475174	0.248497715612092	ULK3	1
GO:0030879	mammary gland development	1/30	142/18866	0.202945443628976	0.300076226475174	0.248497715612092	PML	1
GO:0031333	negative regulation of protein-containing complex assembly	1/30	142/18866	0.202945443628976	0.300076226475174	0.248497715612092	BBS4	1
GO:0002700	regulation of production of molecular mediator of immune response	1/30	144/18866	0.205497581885654	0.301935817164277	0.250037671121542	SEMA7A	1
GO:0010212	response to ionizing radiation	1/30	144/18866	0.205497581885654	0.301935817164277	0.250037671121542	PML	1
GO:0046434	organophosphate catabolic process	1/30	144/18866	0.205497581885654	0.301935817164277	0.250037671121542	NEIL1	1
GO:0061008	hepaticobiliary system development	1/30	144/18866	0.205497581885654	0.301935817164277	0.250037671121542	CYP1A1	1
GO:0002431	Fc receptor mediated stimulatory signaling pathway	1/30	145/18866	0.20677068692483	0.303328696385009	0.251191135721326	CSK	1
GO:0044344	cellular response to fibroblast growth factor stimulus	1/30	146/18866	0.208041819844666	0.304714313838419	0.252338586740452	NPTN	1
GO:0006119	oxidative phosphorylation	1/30	149/18866	0.211843415364388	0.307700537478877	0.254811524239291	COX5A	1
GO:1903364	positive regulation of cellular protein catabolic process	1/30	149/18866	0.211843415364388	0.307700537478877	0.254811524239291	FBXO22	1
GO:0006606	protein import into nucleus	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	PML	1
GO:0035148	tube formation	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	BBS4	1
GO:0035264	multicellular organism growth	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	BBS4	1
GO:0060041	retina development in camera-type eye	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	BBS4	1
GO:0070665	positive regulation of leukocyte proliferation	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	CD276	1
GO:1905039	carboxylic acid transmembrane transport	1/30	150/18866	0.213106689261864	0.307700537478877	0.254811524239291	STRA6	1
GO:0000077	DNA damage checkpoint	1/30	151/18866	0.21436800574627	0.307700537478877	0.254811524239291	PML	1
GO:0016331	morphogenesis of embryonic epithelium	1/30	151/18866	0.21436800574627	0.307700537478877	0.254811524239291	BBS4	1
GO:0051224	negative regulation of protein transport	1/30	151/18866	0.21436800574627	0.307700537478877	0.254811524239291	CSK	1
GO:1903825	organic acid transmembrane transport	1/30	151/18866	0.21436800574627	0.307700537478877	0.254811524239291	STRA6	1
GO:2001056	positive regulation of cysteine-type endopeptidase activity	1/30	151/18866	0.21436800574627	0.307700537478877	0.254811524239291	PML	1
GO:0006090	pyruvate metabolic process	1/30	152/18866	0.215627367746143	0.309032771285947	0.255914767443882	ADPGK	1
GO:0016202	regulation of striated muscle tissue development	1/30	153/18866	0.216884778185793	0.309882845401753	0.256618726829003	FBXO22	1
GO:0071774	response to fibroblast growth factor	1/30	153/18866	0.216884778185793	0.309882845401753	0.256618726829003	NPTN	1
GO:0009132	nucleoside diphosphate metabolic process	1/30	155/18866	0.219393756060583	0.311789156899449	0.25819737255508	ADPGK	1
GO:0048754	branching morphogenesis of an epithelial tube	1/30	155/18866	0.219393756060583	0.311789156899449	0.25819737255508	PML	1
GO:1904950	negative regulation of establishment of protein localization	1/30	155/18866	0.219393756060583	0.311789156899449	0.25819737255508	CSK	1
GO:0000187	activation of MAPK activity	1/30	156/18866	0.220645329323272	0.311789156899449	0.25819737255508	CSPG4	1
GO:0003341	cilium movement	1/30	156/18866	0.220645329323272	0.311789156899449	0.25819737255508	BBS4	1
GO:1901861	regulation of muscle tissue development	1/30	156/18866	0.220645329323272	0.311789156899449	0.25819737255508	FBXO22	1
GO:1902904	negative regulation of supramolecular fiber organization	1/30	156/18866	0.220645329323272	0.311789156899449	0.25819737255508	BBS4	1
GO:0010770	positive regulation of cell morphogenesis involved in differentiation	1/30	157/18866	0.221894962680851	0.311789156899449	0.25819737255508	SEMA7A	1
GO:0048634	regulation of muscle organ development	1/30	157/18866	0.221894962680851	0.311789156899449	0.25819737255508	FBXO22	1
GO:0051017	actin filament bundle assembly	1/30	157/18866	0.221894962680851	0.311789156899449	0.25819737255508	BBS4	1
GO:1903900	regulation of viral life cycle	1/30	157/18866	0.221894962680851	0.311789156899449	0.25819737255508	PML	1
GO:0007519	skeletal muscle tissue development	1/30	158/18866	0.223142659036593	0.312132085279072	0.258481356794538	FBXO22	1
GO:0030203	glycosaminoglycan metabolic process	1/30	158/18866	0.223142659036593	0.312132085279072	0.258481356794538	CSPG4	1
GO:0060402	calcium ion transport into cytosol	1/30	158/18866	0.223142659036593	0.312132085279072	0.258481356794538	PML	1
GO:0032675	regulation of interleukin-6 production	1/30	159/18866	0.224388421289581	0.312936318480089	0.259147354616557	CSK	1
GO:1902600	proton transmembrane transport	1/30	159/18866	0.224388421289581	0.312936318480089	0.259147354616557	COX5A	1
GO:0007286	spermatid development	1/30	160/18866	0.225632252334715	0.314201330489983	0.260194930422122	BBS4	1
GO:0000723	telomere maintenance	1/30	161/18866	0.226874155062714	0.31452241704831	0.260460827115089	PML	1
GO:0031570	DNA integrity checkpoint	1/30	161/18866	0.226874155062714	0.31452241704831	0.260460827115089	PML	1
GO:0061572	actin filament bundle organization	1/30	161/18866	0.226874155062714	0.31452241704831	0.260460827115089	BBS4	1
GO:1903305	regulation of regulated secretory pathway	1/30	162/18866	0.228114132360127	0.315304422951109	0.26110841817128	SCAMP5	1
GO:2001236	regulation of extrinsic apoptotic signaling pathway	1/30	162/18866	0.228114132360127	0.315304422951109	0.26110841817128	PML	1
GO:0009267	cellular response to starvation	1/30	163/18866	0.229352187109336	0.315612965446918	0.261363926934098	FBXO22	1
GO:0021915	neural tube development	1/30	163/18866	0.229352187109336	0.315612965446918	0.261363926934098	BBS4	1
GO:0051494	negative regulation of cytoskeleton organization	1/30	163/18866	0.229352187109336	0.315612965446918	0.261363926934098	BBS4	1
GO:0001764	neuron migration	1/30	164/18866	0.23058832218856	0.316846693080893	0.262385595669177	BBS4	1
GO:0007093	mitotic cell cycle checkpoint	1/30	166/18866	0.233054844829162	0.319295404149204	0.264413410780748	PML	1
GO:0048515	spermatid differentiation	1/30	166/18866	0.233054844829162	0.319295404149204	0.264413410780748	BBS4	1
GO:0042129	regulation of T cell proliferation	1/30	167/18866	0.234285238126228	0.32051045039849	0.26541960917526	CD276	1
GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	1/30	168/18866	0.235513723224694	0.321248982117893	0.266031198594837	NPTN	1
GO:0045931	positive regulation of mitotic cell cycle	1/30	168/18866	0.235513723224694	0.321248982117893	0.266031198594837	CYP1A1	1
GO:0052126	movement in host environment	1/30	169/18866	0.236740302982061	0.321980616154902	0.266637075938059	PML	1
GO:0055002	striated muscle cell development	1/30	169/18866	0.236740302982061	0.321980616154902	0.266637075938059	FBXO22	1
GO:0032635	interleukin-6 production	1/30	170/18866	0.237964980251705	0.322271925181662	0.26687831340141	CSK	1
GO:0007584	response to nutrient	1/30	171/18866	0.23918775788288	0.322271925181662	0.26687831340141	CYP1A1	1
GO:0030307	positive regulation of cell growth	1/30	171/18866	0.23918775788288	0.322271925181662	0.26687831340141	SEMA7A	1
GO:0051170	import into nucleus	1/30	171/18866	0.23918775788288	0.322271925181662	0.26687831340141	PML	1
GO:0051302	regulation of cell division	1/30	171/18866	0.23918775788288	0.322271925181662	0.26687831340141	BBS4	1
GO:0000910	cytokinesis	1/30	172/18866	0.240408638720725	0.322271925181662	0.26687831340141	BBS4	1
GO:0006022	aminoglycan metabolic process	1/30	172/18866	0.240408638720725	0.322271925181662	0.26687831340141	CSPG4	1
GO:0050714	positive regulation of protein secretion	1/30	172/18866	0.240408638720725	0.322271925181662	0.26687831340141	SCAMP5	1
GO:0050806	positive regulation of synaptic transmission	1/30	172/18866	0.240408638720725	0.322271925181662	0.26687831340141	NPTN	1
GO:1990138	neuron projection extension	1/30	172/18866	0.240408638720725	0.322271925181662	0.26687831340141	SEMA7A	1
GO:0006633	fatty acid biosynthetic process	1/30	173/18866	0.241627625606271	0.322296052694481	0.266898293764031	CYP1A1	1
GO:0009152	purine ribonucleotide biosynthetic process	1/30	173/18866	0.241627625606271	0.322296052694481	0.266898293764031	PPCDC	1
GO:0021543	pallium development	1/30	173/18866	0.241627625606271	0.322296052694481	0.266898293764031	BBS4	1
GO:0003205	cardiac chamber development	1/30	174/18866	0.242844721376442	0.322296052694481	0.266898293764031	STRA6	1
GO:0015718	monocarboxylic acid transport	1/30	174/18866	0.242844721376442	0.322296052694481	0.266898293764031	STRA6	1
GO:0030833	regulation of actin filament polymerization	1/30	174/18866	0.242844721376442	0.322296052694481	0.266898293764031	BBS4	1
GO:0032200	telomere organization	1/30	174/18866	0.242844721376442	0.322296052694481	0.266898293764031	PML	1
GO:1901568	fatty acid derivative metabolic process	1/30	175/18866	0.244059928864068	0.323448740951953	0.267852852551175	CYP1A1	1
GO:0030324	lung development	1/30	177/18866	0.246484690302543	0.326198888017408	0.270130291425258	STRA6	1
GO:0060401	cytosolic calcium ion transport	1/30	178/18866	0.247694249898612	0.327335318917004	0.271071387245536	PML	1
GO:1901796	regulation of signal transduction by p53 class mediator	1/30	180/18866	0.250107740926886	0.330057315820063	0.27332551453932	PML	1
GO:0008361	regulation of cell size	1/30	181/18866	0.251311677979877	0.330244782472149	0.273480758542965	SEMA7A	1
GO:0010950	positive regulation of endopeptidase activity	1/30	181/18866	0.251311677979877	0.330244782472149	0.273480758542965	PML	1
GO:0030323	respiratory tube development	1/30	181/18866	0.251311677979877	0.330244782472149	0.273480758542965	STRA6	1
GO:0071346	cellular response to interferon-gamma	1/30	182/18866	0.252513746465861	0.330892311029	0.27401698685089	PML	1
GO:2001252	positive regulation of chromosome organization	1/30	182/18866	0.252513746465861	0.330892311029	0.27401698685089	PML	1
GO:0055001	muscle cell development	1/30	183/18866	0.253713949185087	0.331070090335226	0.27416420861517	FBXO22	1
GO:0120032	regulation of plasma membrane bounded cell projection assembly	1/30	183/18866	0.253713949185087	0.331070090335226	0.27416420861517	BBS4	1
GO:2001235	positive regulation of apoptotic signaling pathway	1/30	183/18866	0.253713949185087	0.331070090335226	0.27416420861517	PML	1
GO:0007416	synapse assembly	1/30	184/18866	0.254912288933759	0.331705949198323	0.274690773071099	NPTN	1
GO:0022900	electron transport chain	1/30	184/18866	0.254912288933759	0.331705949198323	0.274690773071099	COX5A	1
GO:0060491	regulation of cell projection assembly	1/30	185/18866	0.25610876850404	0.332199608339704	0.275099579761203	BBS4	1
GO:0006399	tRNA metabolic process	1/30	186/18866	0.257303390684056	0.332199608339704	0.275099579761203	RPP25	1
GO:0009260	ribonucleotide biosynthetic process	1/30	186/18866	0.257303390684056	0.332199608339704	0.275099579761203	PPCDC	1
GO:0050770	regulation of axonogenesis	1/30	186/18866	0.257303390684056	0.332199608339704	0.275099579761203	SEMA7A	1
GO:0051147	regulation of muscle cell differentiation	1/30	186/18866	0.257303390684056	0.332199608339704	0.275099579761203	FBXO22	1
GO:0008217	regulation of blood pressure	1/30	187/18866	0.258496158257904	0.332199608339704	0.275099579761203	BBS4	1
GO:0043409	negative regulation of MAPK cascade	1/30	187/18866	0.258496158257904	0.332199608339704	0.275099579761203	CSK	1
GO:0045333	cellular respiration	1/30	187/18866	0.258496158257904	0.332199608339704	0.275099579761203	COX5A	1
GO:0061138	morphogenesis of a branching epithelium	1/30	187/18866	0.258496158257904	0.332199608339704	0.275099579761203	PML	1
GO:0008064	regulation of actin polymerization or depolymerization	1/30	190/18866	0.262063361123075	0.336320654646258	0.278512281277546	BBS4	1
GO:0030832	regulation of actin filament length	1/30	191/18866	0.263248738032815	0.336915051556401	0.279004510455687	BBS4	1
GO:0048167	regulation of synaptic plasticity	1/30	191/18866	0.263248738032815	0.336915051556401	0.279004510455687	NPTN	1
GO:0016525	negative regulation of angiogenesis	1/30	192/18866	0.264432274196618	0.337167124116225	0.279213255600281	PML	1
GO:0044272	sulfur compound biosynthetic process	1/30	192/18866	0.264432274196618	0.337167124116225	0.279213255600281	CSPG4	1
GO:0002793	positive regulation of peptide secretion	1/30	193/18866	0.265613972374518	0.337167124116225	0.279213255600281	SCAMP5	1
GO:0030041	actin filament polymerization	1/30	193/18866	0.265613972374518	0.337167124116225	0.279213255600281	BBS4	1
GO:0061136	regulation of proteasomal protein catabolic process	1/30	193/18866	0.265613972374518	0.337167124116225	0.279213255600281	FBXO22	1
GO:0071248	cellular response to metal ion	1/30	193/18866	0.265613972374518	0.337167124116225	0.279213255600281	CYP1A1	1
GO:0046390	ribose phosphate biosynthetic process	1/30	194/18866	0.266793835322559	0.337288141403722	0.279313471868147	PPCDC	1
GO:1902115	regulation of organelle assembly	1/30	194/18866	0.266793835322559	0.337288141403722	0.279313471868147	BBS4	1
GO:2000181	negative regulation of blood vessel morphogenesis	1/30	194/18866	0.266793835322559	0.337288141403722	0.279313471868147	PML	1
GO:0042098	T cell proliferation	1/30	195/18866	0.267971865792799	0.337861825384705	0.279788548352652	CD276	1
GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1/30	195/18866	0.267971865792799	0.337861825384705	0.279788548352652	CSPG4	1
GO:0006164	purine nucleotide biosynthetic process	1/30	197/18866	0.270322440288218	0.339906788125212	0.281482013294867	PPCDC	1
GO:0006694	steroid biosynthetic process	1/30	197/18866	0.270322440288218	0.339906788125212	0.281482013294867	CYP1A1	1
GO:0017038	protein import	1/30	200/18866	0.273834627020766	0.342936519477013	0.283990980195327	PML	1
GO:0031032	actomyosin structure organization	1/30	200/18866	0.273834627020766	0.342936519477013	0.283990980195327	BBS4	1
GO:0051054	positive regulation of DNA metabolic process	1/30	200/18866	0.273834627020766	0.342936519477013	0.283990980195327	PML	1
GO:0001763	morphogenesis of a branching structure	1/30	201/18866	0.275001720194953	0.343476044098917	0.284437768791793	PML	1
GO:0010952	positive regulation of peptidase activity	1/30	201/18866	0.275001720194953	0.343476044098917	0.284437768791793	PML	1
GO:0007179	transforming growth factor beta receptor signaling pathway	1/30	202/18866	0.276167000044626	0.344010428627018	0.284880300797914	PML	1
GO:0034341	response to interferon-gamma	1/30	202/18866	0.276167000044626	0.344010428627018	0.284880300797914	PML	1
GO:0060541	respiratory system development	1/30	204/18866	0.278492130647997	0.346444210526109	0.286895752835972	STRA6	1
GO:0042594	response to starvation	1/30	206/18866	0.280810040546687	0.348862540386231	0.288898408804077	FBXO22	1
GO:1901343	negative regulation of vasculature development	1/30	207/18866	0.281966294500793	0.349833181873989	0.289702211875114	PML	1
GO:0072522	purine-containing compound biosynthetic process	1/30	208/18866	0.283120751393711	0.35079901865914	0.290502036098391	PPCDC	1
GO:0009612	response to mechanical stimulus	1/30	209/18866	0.284273413922288	0.351760073195617	0.291297900068351	STRA6	1
GO:0000956	nuclear-transcribed mRNA catabolic process	1/30	210/18866	0.285424284779464	0.351784488374161	0.291318118651362	EDC3	1
GO:0030100	regulation of endocytosis	1/30	210/18866	0.285424284779464	0.351784488374161	0.291318118651362	SCAMP5	1
GO:0045216	cell-cell junction organization	1/30	210/18866	0.285424284779464	0.351784488374161	0.291318118651362	CSK	1
GO:0051650	establishment of vesicle localization	1/30	212/18866	0.287720662231896	0.353680339739603	0.292888102181834	BBS4	1
GO:0051701	interaction with host	1/30	212/18866	0.287720662231896	0.353680339739603	0.292888102181834	PML	1
GO:0006006	glucose metabolic process	1/30	214/18866	0.290009905216685	0.356025317851536	0.294830014444664	ADPGK	1
GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	1/30	215/18866	0.291151857974754	0.356957534153017	0.295601997030873	PML	1
GO:0050792	regulation of viral process	1/30	217/18866	0.293430439370436	0.359279002536243	0.297524440527559	PML	1
GO:0007601	visual perception	1/30	218/18866	0.294567073335737	0.359726543746391	0.297895056253005	BBS4	1
GO:0007623	circadian rhythm	1/30	218/18866	0.294567073335737	0.359726543746391	0.297895056253005	PML	1
GO:0000075	cell cycle checkpoint	1/30	219/18866	0.295701939691374	0.36016959495046	0.2982619537357	PML	1
GO:0050670	regulation of lymphocyte proliferation	1/30	219/18866	0.295701939691374	0.36016959495046	0.2982619537357	CD276	1
GO:0008154	actin polymerization or depolymerization	1/30	221/18866	0.297966380186661	0.360574102093586	0.298596932291636	BBS4	1
GO:0031669	cellular response to nutrient levels	1/30	221/18866	0.297966380186661	0.360574102093586	0.298596932291636	FBXO22	1
GO:0032944	regulation of mononuclear cell proliferation	1/30	221/18866	0.297966380186661	0.360574102093586	0.298596932291636	CD276	1
GO:0042445	hormone metabolic process	1/30	221/18866	0.297966380186661	0.360574102093586	0.298596932291636	CYP1A1	1
GO:0071241	cellular response to inorganic substance	1/30	221/18866	0.297966380186661	0.360574102093586	0.298596932291636	CYP1A1	1
GO:0017157	regulation of exocytosis	1/30	222/18866	0.299095959623207	0.36100456704845	0.298953406908741	SCAMP5	1
GO:0050953	sensory perception of light stimulus	1/30	222/18866	0.299095959623207	0.36100456704845	0.298953406908741	BBS4	1
GO:0002699	positive regulation of immune effector process	1/30	223/18866	0.300223782043894	0.361897659750586	0.299692990643572	SEMA7A	1
GO:0043583	ear development	1/30	224/18866	0.301349850087594	0.362786335653838	0.300428916759652	STRA6	1
GO:0045732	positive regulation of protein catabolic process	1/30	225/18866	0.302474166389352	0.363614573081531	0.301114792849149	FBXO22	1
GO:0008037	cell recognition	1/30	226/18866	0.303596733580399	0.363614573081531	0.301114792849149	NPTN	1
GO:0044706	multi-multicellular organism process	1/30	226/18866	0.303596733580399	0.363614573081531	0.301114792849149	CYP1A1	1
GO:2001020	regulation of response to DNA damage stimulus	1/30	226/18866	0.303596733580399	0.363614573081531	0.301114792849149	PML	1
GO:0006364	rRNA processing	1/30	227/18866	0.304717554288156	0.364489074552371	0.301838980900818	RPP25	1
GO:0048762	mesenchymal cell differentiation	1/30	229/18866	0.306953966744451	0.365757408649518	0.30288930777768	SEMA7A	1
GO:0050920	regulation of chemotaxis	1/30	229/18866	0.306953966744451	0.365757408649518	0.30288930777768	SEMA7A	1
GO:0051648	vesicle localization	1/30	229/18866	0.306953966744451	0.365757408649518	0.30288930777768	BBS4	1
GO:0010001	glial cell differentiation	1/30	230/18866	0.308069563728819	0.366076313764673	0.303153397984171	CSK	1
GO:0097191	extrinsic apoptotic signaling pathway	1/30	230/18866	0.308069563728819	0.366076313764673	0.303153397984171	PML	1
GO:0001649	osteoblast differentiation	1/30	231/18866	0.309183424701567	0.366076313764673	0.303153397984171	SEMA7A	1
GO:0032271	regulation of protein polymerization	1/30	231/18866	0.309183424701567	0.366076313764673	0.303153397984171	BBS4	1
GO:0043903	regulation of symbiotic process	1/30	231/18866	0.309183424701567	0.366076313764673	0.303153397984171	PML	1
GO:0007050	cell cycle arrest	1/30	234/18866	0.312514617615625	0.369551506001747	0.306031257861208	PML	1
GO:0045444	fat cell differentiation	1/30	235/18866	0.31362156058855	0.370391032948249	0.306726482974011	BBS4	1
GO:0060560	developmental growth involved in morphogenesis	1/30	236/18866	0.314726780554324	0.371226404876339	0.307418267252477	SEMA7A	1
GO:0048588	developmental cell growth	1/30	237/18866	0.315830280102546	0.372057640575347	0.308106626256338	SEMA7A	1
GO:0016072	rRNA metabolic process	1/30	238/18866	0.316932061819059	0.372884758735412	0.308791575463183	RPP25	1
GO:2000116	regulation of cysteine-type endopeptidase activity	1/30	239/18866	0.31803212828596	0.373707777948111	0.309473130268984	PML	1
GO:0032886	regulation of microtubule-based process	1/30	240/18866	0.319130482081602	0.37405620575645	0.309761668669526	BBS4	1
GO:0070663	regulation of leukocyte proliferation	1/30	240/18866	0.319130482081602	0.37405620575645	0.309761668669526	CD276	1
GO:0016358	dendrite development	1/30	247/18866	0.32677121965396	0.38253142777559	0.316780129731238	BBS4	1
GO:0009636	response to toxic substance	1/30	250/18866	0.330020387690888	0.385850904405513	0.319529039130869	CYP1A1	1
GO:1901991	negative regulation of mitotic cell cycle phase transition	1/30	251/18866	0.331100071208791	0.386436585828375	0.320014050880608	PML	1
GO:0006486	protein glycosylation	1/30	252/18866	0.332178072705634	0.386436585828375	0.320014050880608	MPI	1
GO:0043413	macromolecule glycosylation	1/30	252/18866	0.332178072705634	0.386436585828375	0.320014050880608	MPI	1
GO:0071560	cellular response to transforming growth factor beta stimulus	1/30	252/18866	0.332178072705634	0.386436585828375	0.320014050880608	PML	1
GO:0031668	cellular response to extracellular stimulus	1/30	253/18866	0.333254394711588	0.386724316251134	0.320252324847219	FBXO22	1
GO:0051924	regulation of calcium ion transport	1/30	253/18866	0.333254394711588	0.386724316251134	0.320252324847219	PML	1
GO:0003007	heart morphogenesis	1/30	258/18866	0.338610900677352	0.391479517139987	0.32419017947848	BBS4	1
GO:0051607	defense response to virus	1/30	258/18866	0.338610900677352	0.391479517139987	0.32419017947848	PML	1
GO:0071559	response to transforming growth factor beta	1/30	258/18866	0.338610900677352	0.391479517139987	0.32419017947848	PML	1
GO:0006302	double-strand break repair	1/30	262/18866	0.342866131340541	0.395419160124505	0.327452658127587	PML	1
GO:0061448	connective tissue development	1/30	262/18866	0.342866131340541	0.395419160124505	0.327452658127587	BBS4	1
GO:0050730	regulation of peptidyl-tyrosine phosphorylation	1/30	263/18866	0.343925796792045	0.396151565934541	0.328059174587864	CSPG4	1
GO:0048863	stem cell differentiation	1/30	264/18866	0.34498381034342	0.396628357236972	0.328454012762382	SEMA7A	1
GO:0030522	intracellular receptor signaling pathway	1/30	265/18866	0.346040174481131	0.396628357236972	0.328454012762382	PML	1
GO:0031330	negative regulation of cellular catabolic process	1/30	265/18866	0.346040174481131	0.396628357236972	0.328454012762382	PML	1
GO:0070085	glycosylation	1/30	265/18866	0.346040174481131	0.396628357236972	0.328454012762382	MPI	1
GO:0009165	nucleotide biosynthetic process	1/30	266/18866	0.347094891688032	0.397349121404827	0.329050888600601	PPCDC	1
GO:0072331	signal transduction by p53 class mediator	1/30	267/18866	0.348147964443374	0.398066238756946	0.329644744454898	PML	1
GO:0015850	organic hydroxy compound transport	1/30	268/18866	0.349199395222809	0.398292219734573	0.329831882760959	STRA6	1
GO:0033673	negative regulation of kinase activity	1/30	268/18866	0.349199395222809	0.398292219734573	0.329831882760959	CSK	1
GO:1901293	nucleoside phosphate biosynthetic process	1/30	269/18866	0.350249186498393	0.399001820516484	0.33041951402843	PPCDC	1
GO:1901988	negative regulation of cell cycle phase transition	1/30	270/18866	0.351297340738595	0.399707827937938	0.331004169579113	PML	1
GO:0030258	lipid modification	1/30	271/18866	0.352343860408301	0.400410257930505	0.331585862606184	CYP1A1	1
GO:0007281	germ cell development	1/30	275/18866	0.356513642554678	0.404655995746368	0.335101823069706	BBS4	1
GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules	1/30	277/18866	0.358588790029293	0.406209603731213	0.336388389618898	NPTN	1
GO:0015980	energy derivation by oxidation of organic compounds	1/30	278/18866	0.359623936422274	0.406209603731213	0.336388389618898	COX5A	1
GO:0045165	cell fate commitment	1/30	278/18866	0.359623936422274	0.406209603731213	0.336388389618898	PML	1
GO:0110053	regulation of actin filament organization	1/30	278/18866	0.359623936422274	0.406209603731213	0.336388389618898	BBS4	1
GO:0007548	sex differentiation	1/30	280/18866	0.361689386701548	0.408048606762447	0.337911296173787	STRA6	1
GO:0001822	kidney development	1/30	283/18866	0.364775492293546	0.410537435838213	0.33997233362131	STRA6	1
GO:0046651	lymphocyte proliferation	1/30	283/18866	0.364775492293546	0.410537435838213	0.33997233362131	CD276	1
GO:0032943	mononuclear cell proliferation	1/30	286/18866	0.367847172206577	0.413495676709321	0.342422098160593	CD276	1
GO:0072593	reactive oxygen species metabolic process	1/30	288/18866	0.369886976717203	0.41528826627816	0.343906569016945	CYP1A1	1
GO:0060485	mesenchyme development	1/30	290/18866	0.371920417985273	0.416568727467298	0.344966938524281	SEMA7A	1
GO:0097193	intrinsic apoptotic signaling pathway	1/30	290/18866	0.371920417985273	0.416568727467298	0.344966938524281	PML	1
GO:0031503	protein-containing complex localization	1/30	291/18866	0.372934758395503	0.417203992305761	0.34549301105932	NPTN	1
GO:0072001	renal system development	1/30	292/18866	0.373947515178714	0.417835966061964	0.346016358198772	STRA6	1
GO:0051146	striated muscle cell differentiation	1/30	295/18866	0.376976307621795	0.420716381592267	0.348401674382268	FBXO22	1
GO:0051348	negative regulation of transferase activity	1/30	296/18866	0.377982753735162	0.421335614378622	0.348914470529597	CSK	1
GO:0051258	protein polymerization	1/30	300/18866	0.381992844619111	0.42529752270839	0.352195387451862	BBS4	1
GO:0048511	rhythmic process	1/30	305/18866	0.386970324796743	0.430325760471229	0.35635934809712	PML	1
GO:0002440	production of molecular mediator of immune response	1/30	306/18866	0.387961159894857	0.430914002597502	0.356846480404543	SEMA7A	1
GO:0010769	regulation of cell morphogenesis involved in differentiation	1/30	310/18866	0.39190904182934	0.433235943159685	0.358769314919849	SEMA7A	1
GO:0034599	cellular response to oxidative stress	1/30	310/18866	0.39190904182934	0.433235943159685	0.358769314919849	PML	1
GO:0042254	ribosome biogenesis	1/30	310/18866	0.39190904182934	0.433235943159685	0.358769314919849	RPP25	1
GO:0090287	regulation of cellular response to growth factor stimulus	1/30	310/18866	0.39190904182934	0.433235943159685	0.358769314919849	NPTN	1
GO:0070661	leukocyte proliferation	1/30	313/18866	0.394853787110054	0.435459318408605	0.360610525990767	CD276	1
GO:1903532	positive regulation of secretion by cell	1/30	313/18866	0.394853787110054	0.435459318408605	0.360610525990767	SCAMP5	1
GO:0098656	anion transmembrane transport	1/30	315/18866	0.39680928726165	0.43709925031301	0.361968578698877	STRA6	1
GO:0006470	protein dephosphorylation	1/30	323/18866	0.404570380654597	0.444598545525017	0.368178859835688	PTPN9	1
GO:0009895	negative regulation of catabolic process	1/30	323/18866	0.404570380654597	0.444598545525017	0.368178859835688	PML	1
GO:0071496	cellular response to external stimulus	1/30	326/18866	0.40745583038533	0.447242693822956	0.370368519508151	FBXO22	1
GO:0001655	urogenital system development	1/30	330/18866	0.411282077767689	0.450382838682222	0.372968921523948	STRA6	1
GO:0071375	cellular response to peptide hormone stimulus	1/30	330/18866	0.411282077767689	0.450382838682222	0.372968921523948	CSK	1
GO:0032147	activation of protein kinase activity	1/30	331/18866	0.412234901336256	0.450897025728871	0.37339472768657	CSPG4	1
GO:0008202	steroid metabolic process	1/30	332/18866	0.413186234109923	0.451408379888241	0.373818187891881	CYP1A1	1
GO:0051047	positive regulation of secretion	1/30	340/18866	0.420743497258829	0.459076840615702	0.380168557581007	SCAMP5	1
GO:0019058	viral life cycle	1/30	341/18866	0.421681513834573	0.459076840615702	0.380168557581007	PML	1
GO:0045930	negative regulation of mitotic cell cycle	1/30	341/18866	0.421681513834573	0.459076840615702	0.380168557581007	PML	1
GO:0090150	establishment of protein localization to membrane	1/30	342/18866	0.422618061990307	0.459560200276173	0.380568835113342	CSK	1
GO:0046942	carboxylic acid transport	1/30	350/18866	0.430057849788792	0.467105906697256	0.386817550082683	STRA6	1
GO:0050708	regulation of protein secretion	1/30	352/18866	0.431903267159826	0.468564823558276	0.38802570146305	SCAMP5	1
GO:0015849	organic acid transport	1/30	353/18866	0.432823808479109	0.469018133926839	0.388401094716872	STRA6	1
GO:0051222	positive regulation of protein transport	1/30	354/18866	0.433742907800971	0.469468831761375	0.388774324491284	SCAMP5	1
GO:0033044	regulation of chromosome organization	1/30	356/18866	0.43557678917352	0.47090746732201	0.38996568061641	PML	1
GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	1/30	359/18866	0.438316850675084	0.47266333526587	0.391419741733117	PML	1
GO:0010948	negative regulation of cell cycle process	1/30	359/18866	0.438316850675084	0.47266333526587	0.391419741733117	PML	1
GO:0032956	regulation of actin cytoskeleton organization	1/30	360/18866	0.439227343703654	0.47266333526587	0.391419741733117	BBS4	1
GO:0062197	cellular response to chemical stress	1/30	360/18866	0.439227343703654	0.47266333526587	0.391419741733117	PML	1
GO:0043687	post-translational protein modification	1/30	363/18866	0.441950270642201	0.475045625010568	0.393392552330069	FBXO22	1
GO:0051052	regulation of DNA metabolic process	1/30	365/18866	0.44375845002817	0.47644031516258	0.39454751658976	PML	1
GO:0010038	response to metal ion	1/30	366/18866	0.444660414597607	0.476859961861571	0.394895032443609	CYP1A1	1
GO:0007018	microtubule-based movement	1/30	368/18866	0.44646010420532	0.478240272357708	0.396038088690199	BBS4	1
GO:0045861	negative regulation of proteolysis	1/30	369/18866	0.447357833520589	0.478652360865492	0.396379345490237	PML	1
GO:1904951	positive regulation of establishment of protein localization	1/30	370/18866	0.448254155356259	0.479062001085211	0.396718574825458	SCAMP5	1
GO:0006790	sulfur compound metabolic process	1/30	371/18866	0.44914907184303	0.479469203695133	0.397055785538701	CSPG4	1
GO:1902903	regulation of supramolecular fiber organization	1/30	373/18866	0.450934697277127	0.480825225782353	0.398178728182149	BBS4	1
GO:0022412	cellular process involved in reproduction in multicellular organism	1/30	375/18866	0.452714726806349	0.482172191906762	0.399294171444196	BBS4	1
GO:0006402	mRNA catabolic process	1/30	376/18866	0.453602648400411	0.482567013634645	0.399621129359541	EDC3	1
GO:0060271	cilium assembly	1/30	377/18866	0.454489177364608	0.482959456128905	0.399946116995111	BBS4	1
GO:0002791	regulation of peptide secretion	1/30	381/18866	0.458021409056918	0.486159243060414	0.402595909523714	SCAMP5	1
GO:0006909	phagocytosis	1/30	382/18866	0.458901006445519	0.486539362515533	0.402910692261975	CSK	1
GO:0006066	alcohol metabolic process	1/30	385/18866	0.461531526839452	0.488772888242008	0.404760309098701	CYP1A1	1
GO:0014706	striated muscle tissue development	1/30	389/18866	0.465019664413541	0.491712404110598	0.407194567176825	FBXO22	1
GO:0031331	positive regulation of cellular catabolic process	1/30	390/18866	0.465888279993321	0.491712404110598	0.407194567176825	FBXO22	1
GO:0042692	muscle cell differentiation	1/30	390/18866	0.465888279993321	0.491712404110598	0.407194567176825	FBXO22	1
GO:0030198	extracellular matrix organization	1/30	395/18866	0.470210948437889	0.494176413409641	0.409235050987393	LOXL1	1
GO:0006631	fatty acid metabolic process	1/30	396/18866	0.471071414657739	0.494176413409641	0.409235050987393	CYP1A1	1
GO:0010959	regulation of metal ion transport	1/30	396/18866	0.471071414657739	0.494176413409641	0.409235050987393	PML	1
GO:0043062	extracellular structure organization	1/30	396/18866	0.471071414657739	0.494176413409641	0.409235050987393	LOXL1	1
GO:0040013	negative regulation of locomotion	1/30	397/18866	0.471930529847792	0.494176413409641	0.409235050987393	SEMA7A	1
GO:0042493	response to drug	1/30	397/18866	0.471930529847792	0.494176413409641	0.409235050987393	CYP1A1	1
GO:0044782	cilium organization	1/30	397/18866	0.471930529847792	0.494176413409641	0.409235050987393	BBS4	1
GO:1901653	cellular response to peptide	1/30	398/18866	0.47278829605628	0.494519596659764	0.409519246289013	CSK	1
GO:0034470	ncRNA processing	1/30	400/18866	0.474499789706531	0.495199444962185	0.410082239072876	RPP25	1
GO:0051271	negative regulation of cellular component movement	1/30	400/18866	0.474499789706531	0.495199444962185	0.410082239072876	SEMA7A	1
GO:0045765	regulation of angiogenesis	1/30	403/18866	0.477056963854068	0.497311896397593	0.411831592436208	PML	1
GO:0018205	peptidyl-lysine modification	1/30	405/18866	0.478755059455772	0.497969309333595	0.412376006149781	LOXL1	1
GO:0032970	regulation of actin filament-based process	1/30	405/18866	0.478755059455772	0.497969309333595	0.412376006149781	BBS4	1
GO:0001503	ossification	1/30	412/18866	0.484656519821039	0.50354625054903	0.416994356521677	SEMA7A	1
GO:2001233	regulation of apoptotic signaling pathway	1/30	413/18866	0.485494295067889	0.50385559210049	0.417250526994708	PML	1
GO:0006401	RNA catabolic process	1/30	415/18866	0.487165897716833	0.505028647299783	0.418221951958076	EDC3	1
GO:0010639	negative regulation of organelle organization	1/30	416/18866	0.487999729111798	0.505331572987023	0.418472809355756	BBS4	1
GO:0050727	regulation of inflammatory response	1/30	425/18866	0.495445471434617	0.512472976550441	0.424386714941077	SEMA7A	1
GO:0006816	calcium ion transport	1/30	426/18866	0.496266285699405	0.512753537715997	0.424619051936077	PML	1
GO:0030099	myeloid cell differentiation	1/30	431/18866	0.500351033158207	0.516061383751409	0.427358329862396	PML	1
GO:0051656	establishment of organelle localization	1/30	432/18866	0.501164131558274	0.516061383751409	0.427358329862396	BBS4	1
GO:0050808	synapse organization	1/30	433/18866	0.501975950808207	0.516061383751409	0.427358329862396	NPTN	1
GO:0007015	actin filament organization	1/30	434/18866	0.502786492851051	0.516061383751409	0.427358329862396	BBS4	1
GO:0034329	cell junction assembly	1/30	434/18866	0.502786492851051	0.516061383751409	0.427358329862396	NPTN	1
GO:0052548	regulation of endopeptidase activity	1/30	434/18866	0.502786492851051	0.516061383751409	0.427358329862396	PML	1
GO:0048608	reproductive structure development	1/30	443/18866	0.5100242161149	0.522584443140551	0.43276017517365	STRA6	1
GO:0001933	negative regulation of protein phosphorylation	1/30	444/18866	0.510822092330313	0.522584443140551	0.43276017517365	CSK	1
GO:1901342	regulation of vasculature development	1/30	444/18866	0.510822092330313	0.522584443140551	0.43276017517365	PML	1
GO:0043434	response to peptide hormone	1/30	447/18866	0.513208192487186	0.523876634125322	0.433830258304267	CSK	1
GO:0061458	reproductive system development	1/30	447/18866	0.513208192487186	0.523876634125322	0.433830258304267	STRA6	1
GO:0043254	regulation of protein-containing complex assembly	1/30	449/18866	0.514792671240573	0.524919740183011	0.434694070394686	BBS4	1
GO:0007608	sensory perception of smell	1/30	452/18866	0.517160045331506	0.526757993771064	0.436216356324207	BBS4	1
GO:0009896	positive regulation of catabolic process	1/30	454/18866	0.518732087444351	0.526857242494151	0.436298545710731	FBXO22	1
GO:0050804	modulation of chemical synaptic transmission	1/30	454/18866	0.518732087444351	0.526857242494151	0.436298545710731	NPTN	1
GO:0007389	pattern specification process	1/30	455/18866	0.519516251977084	0.526857242494151	0.436298545710731	BBS4	1
GO:0099177	regulation of trans-synaptic signaling	1/30	455/18866	0.519516251977084	0.526857242494151	0.436298545710731	NPTN	1
GO:0009306	protein secretion	1/30	462/18866	0.524970923868564	0.531810935905939	0.440400775038032	SCAMP5	1
GO:0035592	establishment of protein localization to extracellular region	1/30	463/18866	0.525745259463214	0.532017708328828	0.440572006445941	SCAMP5	1
GO:0052547	regulation of peptidase activity	1/30	466/18866	0.528060952343378	0.533782089421854	0.442033117431761	PML	1
GO:0002697	regulation of immune effector process	1/30	470/18866	0.53113154621217	0.535725116341572	0.44364216776072	SEMA7A	1
GO:0071692	protein localization to extracellular region	1/30	470/18866	0.53113154621217	0.535725116341572	0.44364216776072	SCAMP5	1
GO:0070838	divalent metal ion transport	1/30	471/18866	0.531896171870663	0.535916985264933	0.443801057352582	PML	1
GO:0072511	divalent inorganic cation transport	1/30	478/18866	0.537214901615467	0.540692020719774	0.447755337291493	PML	1
GO:0043087	regulation of GTPase activity	1/30	481/18866	0.539476430913332	0.542383092717822	0.449155739893813	BBS4	1
GO:0022613	ribonucleoprotein complex biogenesis	1/30	482/18866	0.540227897166941	0.542553959156896	0.449297237007008	RPP25	1
GO:0042326	negative regulation of phosphorylation	1/30	484/18866	0.541727275258859	0.543474782598404	0.450059784991514	CSK	1
GO:0016311	dephosphorylation	1/30	492/18866	0.547677659362851	0.548854195688013	0.454514559299376	PTPN9	1
GO:0034660	ncRNA metabolic process	1/30	493/18866	0.548416185008825	0.549004614391881	0.454639123330108	RPP25	1
GO:0022604	regulation of cell morphogenesis	1/30	499/18866	0.552822921459285	0.552822921459285	0.457801121849286	SEMA7A	1
